Profiles

Gregory Woods

Professor Greg Woods

Greg Woods

Principal Research Fellow

Room 437C , Medical Science 2 (MS2)

+61 3 6226 4832 (phone)

G.M.Woods@utas.edu.au

Greg Woods is a Professor of immunology at the School of Medicine and a Principal Research Fellow at the Menzies Institute for Medical Research. He teaches immunology and his research involves the immunology of Devil Facial Tumour Disease (DFTD). In 2011, as part of a five-member team, he was awarded the Sherman Eureka Award for Environmental Science and received a Fellowship of the Faculty of Science, Royal College of Pathologists of Australasia; and in 2015 received The Australian Society for Medical Research Certificate in Recognition of Distinguished Service to Medicine, Science and Community.

Biography

Professor Greg Woods completed a BSc (Hons) undergraduate degree in 1978, at Monash University and completed postgraduate (PhD) degree at the University of Tasmania, in 1984. In 1985 worked as a junior research fellow at the Department of Medicine, University of Tasmania. For the next two years he was at the Mt. Sinai Hospital Research institute, Toronto Canada as postdoctoral fellow. In 1989 he obtained a lectureship at the University of Tasmania and was promoted to professor in January 2013. In 1993 he was a visiting scientist at the Clinical Research Centre, Northwick Park Hospital, Harrow, England and in 2003 a visiting scientist at the University of Edinburgh, Edinburgh, Scotland.

Career summary

Qualifications

FFSc (RCPA), Royal College of Pathologists of Australasia, Australia. 2011
PhD, University of Tasmania, Australia. 1984 Thesis: Studies on Human T Lymphocyte Colonies
BSc (Hons), Monash University, Australia. 1978 Thesis: Biology of Actin-like Tissue

Memberships

Professional practice

Australasian Society for Immunology (2001 - present)
Australian Society for Medical Research (Board of Directors 1989-92)
Molecular and Experimental Society for Medical Research
Scientific Advisory Research Committee, Cancer Council of Tasmania
David Collins Leukaemia Foundation of Tasmania (1992 - present)

Administrative expertise

Prof Woods regularly reviews research grant proposals for:

National Health & Medical Research Council (NHMRC)
David Collins Leukaemia Foundation
Royal Hobart Hospital Research Foundation
Cancer Council
Australian Research Council (ARC)
University of Tasmania Institutional Research Grants

Teaching

Immunology

Teaching expertise

Prof Woods teaches within a range of undergraduate units offered by the School of Medicine with a focus on immunology but also in medical microbiology, pathology and molecular biology. Greg's versatile teaching ability has enabled him to engage students from a range of backgrounds including science, medicine and pharmacy students. His successful use of analogies and visual aids to assist in the explanation of complex scientific ideas has made him a popular lecturer.

Teaching responsibility

Research Invitations

Prof Woods is regularly invited to present at both national and international scientific meetings.

View more on Professor Gregory Woods in WARP

Expertise

Cellular Immunology
Vaccine Research
Cancer Immunology
Comparative Immunology

Research Themes

Greg's research aligns with Environment, Resources and Sustainability. Some environmental stressors require immediate solutions to prevent extinction. Emerging infectious diseases, like the Devil Facial Tumour Disease (DFTD), must be managed while infectious zoonotic diseases threaten both biodiversity and human populations. Since commencing research on devil facial tumour disease in 2006 when this disease was first identified as a serious threat to the survival of the Tasmanian devil Greg has been leading the immunology program. With limited and basic tools to analyse the immune response Greg's laboratory has been able to clearly demonstrate that the Tasmanian devil has a robust immune response. Collaboration has been an important aspect in understanding DFTD and the collaborations have resulted in significant advances including the understanding that Tasmanian devils have a limited MHC-diversity and that DFTD derived from a Schwann cell. This latter observation has led to the use of periaxin as an accurate and effective diagnostic marker of DFTD.

The current research emphasis is to understand the devil's immune response to DFTD with the ultimate objective of a vaccine. The research has now provided important advances, one of the most significant is that immunised devils can produce an immune response to DFTD. The challenge is to translate this into a vaccine that can be used to protect wild devils.

Collaboration

Greg collaborates with groups within the University of Tasmania, Australia and overseas.

Awards

The Australian Society for Medical Research Certificate in Recognition of Distinguished Service to Medicine, Science and Community (2015)
The Sherman Eureka Award for Environmental Science (as part of a team of 5, 2011)
Fellowship of the Faculty of Science, Royal College of Pathologists of Australasia (2011)

Current projects

Greg's current research emphasis is to understand the devil's immune response to DFTD with the ultimate objective of a vaccine. The research has now provided important advances, one of the most significant is that immunised devils can produce an immune response to DFTD. The challenge is to translate this into a vaccine that can be used to protect wild devils.

Fields of Research

Cellular immunology (320404)
Veterinary immunology (300906)
Tumour immunology (320409)
Animal immunology (310905)
Haematology (320102)
Oncology and carcinogenesis (321199)
Humoural immunology and immunochemistry (320405)
Conservation and biodiversity (410401)
Epidemiology (420299)
Immunology (320499)
Autoimmunity (320403)
Cancer cell biology (321101)
Host-parasite interactions (310407)
Medical biochemistry and metabolomics (320599)
Respiratory diseases (320103)
Medical biochemistry - proteins and peptides (incl. medical proteomics) (320506)
Zoology (310999)
Animal cell and molecular biology (310902)
Veterinary pathology (300910)
Proteomics and intermolecular interactions (excl. medical proteomics) (310109)
Infectious diseases (320211)
Cell metabolism (310103)
Medical genetics (excl. cancer genetics) (320213)
Other biological sciences (319999)
Medical bacteriology (320701)
Biochemistry and cell biology (310199)
Transplantation immunology (320408)
Veterinary epidemiology (300905)
Innate immunity (320407)
Veterinary diagnosis and diagnostics (300904)
Receptors and membrane biology (310110)
Immunogenetics (incl. genetic immunology) (320406)
Cardiology (incl. cardiovascular diseases) (320101)
Microbiology (310799)
Cancer therapy (excl. chemotherapy and radiation therapy) (321104)
Genetics (310599)
Cell development, proliferation and death (310102)
Genomics (310509)
Pathology (excl. oral pathology) (320220)
Ecosystem function (410203)
Central nervous system (320903)
Medicine, nursing and health curriculum and pedagogy (390110)
Community ecology (excl. invasive species ecology) (310302)
Medical parasitology (320704)
Chemotherapy (321105)
Health services and systems (420399)
Clinical sciences (320299)
Rural clinical health (320224)
Medical virology (320705)
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies) (320402)
Aquaculture (300501)
Veterinary bacteriology (300903)
Gene expression (incl. microarray and other genome-wide approaches) (310505)
Cellular nervous system (320902)
Cancer genetics (321103)
Molecular targets (321108)
Plant physiology (310806)
Medical biochemistry - nucleic acids (320505)
Occupational and workplace health and safety (350505)
Toxicology (incl. clinical toxicology) (321407)
Ecology (310399)
Infectious agents (310702)
Population ecology (310307)
Veterinary medicine (excl. urology) (300907)
Separation science (340109)
Health psychology (520304)
Genome structure and regulation (310508)
Peripheral nervous system (320906)
Veterinary surgery (300912)
Animal physiology - systems (310910)
Medical microbiology (320799)
Health informatics and information systems (420308)
Freshwater ecology (310304)
Haematological tumours (321106)
Medical biochemistry - lipids (320504)
Mycology (310705)
Veterinary sciences (300999)
Biological adaptation (310403)
Environmental management (410404)

Research Objectives

Clinical health (200199)
Terrestrial biodiversity (180606)
Other health (209999)
Expanding knowledge in the biological sciences (280102)
Other environmental management (189999)
Control of pests, diseases and exotic species in terrestrial environments (180602)
Diagnosis of human diseases and conditions (200101)
Expanding knowledge in the environmental sciences (280111)
Expanding knowledge in the agricultural, food and veterinary sciences (280101)
Veterinary biological preventatives (241601)
Veterinary diagnostics (241602)
Disease distribution and transmission (incl. surveillance and response) (200404)
Preventive medicine (200412)
Public health (excl. specific population health) (200499)
Learner and learning (160199)
Assessment and management of Antarctic and Southern Ocean ecosystems (180403)
Health status (incl. wellbeing) (200407)
Control of pests, diseases and exotic species in marine environments (180503)
Sheep for meat (100412)
Veterinary pharmaceutical products (241699)
Aquaculture fin fish (excl. tuna) (100202)
Expanding knowledge in the health sciences (280112)
Other education and training (169999)
Occupational health (200507)
Expanding knowledge in the chemical sciences (280105)
Coastal or estuarine biodiversity (180203)
Assessment and management of terrestrial ecosystems (180601)

Publications

Prof Woods publishes frequently and in high quality journals including Cell, Science and Journal of Immunology.

Total publications

202

Highlighted publications

(11 outputs)

Year	Type	Citation
2020	Journal Article	Flies AS, Darby JM, Lennard PR, Murphy PR, Ong C, et al., 'A novel system to map protein interactions reveals evolutionarily conserved immune evasion pathways on transmissible cancers', Science Advances, 6, (27) Article eaba5031. ISSN 2375-2548 (2020) [Refereed Article] DOI: 10.1126/sciadv.aba5031 [eCite] [Details] Citations: Scopus - 12Web of Science - 10 Co-authors: Flies AS; Darby JM; Lennard PR; Murphy PR; Ong C; Pinfold TL; De Luca A; Lyons AB; Patchett AL Tweet
2020	Journal Article	Patchett AL, Flies AS, Lyons AB, Woods GM, 'Curse of the devil: molecular insights into the emergence of transmissible cancers in the Tasmanian devil (Sarcophilus harrisii)', Cellular and Molecular Life Sciences, 77, (13) pp. 2507-2525. ISSN 1420-682X (2020) [Refereed Article] DOI: 10.1007/s00018-019-03435-4 [eCite] [Details] Citations: Scopus - 9Web of Science - 10 Co-authors: Patchett AL; Flies AS; Lyons AB Tweet
2019	Review	Patchett A, Woods G, 'Targeting transmissible cancers in animals', Science, 365, (6452) pp. 438-440. ISSN 0036-8075 (2019) [Review Several Works] DOI: 10.1126/science.aau8936 [eCite] [Details] Citations: Scopus - 3Web of Science - 3 Co-authors: Patchett A Tweet
2019	Journal Article	Patchett AL, Coorens THH, Darby J, Wilson R, McKay MJ, et al., 'Two of a kind: transmissible Schwann cell cancers in the endangered Tasmanian devil (Sarcophilus harrisii)', Cellular and Molecular Life Sciences, 77 pp. 1847-1858. ISSN 1420-682X (2019) [Refereed Article] DOI: 10.1007/s00018-019-03259-2 [eCite] [Details] Citations: Scopus - 16Web of Science - 15 Co-authors: Patchett AL; Darby J; Wilson R; Pye RJ; Flies AS; Lyons AB; Tovar C Tweet
2018	Journal Article	Woods GM, Fox S, Flies A, Tovar CD, Jones M, et al., 'Two decades of the impact of Tasmanian Devil Facial Tumour Disease (DFTD)', Integrative and Comparative Biology, 58, (6) pp. 1043-1054. ISSN 1540-7063 (2018) [Refereed Article] DOI: 10.1093/icb/icy118 [eCite] [Details] Citations: Scopus - 7Web of Science - 6 Co-authors: Flies A; Tovar CD; Jones M; Hamede R; Lyons AB; Bettiol S Tweet
2017	Journal Article	Tovar C, Pye RJ, Kreiss A, Cheng Y, Brown GK, et al., 'Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devils', Scientific Reports, 7 Article 43827. ISSN 2045-2322 (2017) [Refereed Article] DOI: 10.1038/srep43827 [eCite] [Details] Citations: Scopus - 41Web of Science - 41 Co-authors: Tovar C; Pye RJ; Kreiss A; Brown GK; Darby J; Malley RC; Lyons AB Tweet
2016	Journal Article	Pye RJ, Hamede R, Siddle HV, Caldwell A, Knowles GW, et al., 'Demonstration of immune responses against devil facial tumour disease in wild Tasmanian devils', Biology Letters, 12, (10) Article 20160553. ISSN 1744-9561 (2016) [Refereed Article] DOI: 10.1098/rsbl.2016.0553 [eCite] [Details] Citations: Scopus - 61Web of Science - 60 Co-authors: Pye RJ; Hamede R; Kreiss A; Jones ME; Lyons AB Tweet
2011	Journal Article	Kreiss A, Cheng Y, Kimble F, Wells B, Donovan S, et al., 'Allorecognition in the Tasmanian devil (Sarcophilus harrisii), an endangered marsupial species with limited genetic diversity', PL o S One, 6, (7) Article e22402. ISSN 1932-6203 (2011) [Refereed Article] DOI: 10.1371/journal.pone.0022402 [eCite] [Details] Citations: Scopus - 50Web of Science - 48 Co-authors: Kreiss A; Kimble F; Wells B Tweet
2011	Journal Article	Kreiss A, Tovar C, Obendorf DL, Dun K, Woods GM, 'A murine xenograft model for a transmissible cancer in Tasmanian devils', Veterinary Pathology, 48, (2) pp. 475-481. ISSN 0300-9858 (2011) [Refereed Article] DOI: 10.1177/0300985810380398 [eCite] [Details] Citations: Scopus - 21Web of Science - 19 Co-authors: Kreiss A; Tovar C; Obendorf DL Tweet
2011	Journal Article	Tovar C, Obendorf D, Murchison EP, Papenfuss AT, Kreiss A, et al., 'Tumor-specific diagnostic marker for transmissible facial tumors of Tasmanian devils: immunohistochemistry studies', Veterinary Pathology, 48, (6) pp. 1195-1203. ISSN 1544-2217 (2011) [Refereed Article] DOI: 10.1177/0300985811400447 [eCite] [Details] Citations: Scopus - 48Web of Science - 47 Co-authors: Tovar C; Obendorf D; Kreiss A Tweet
2010	Journal Article	Murchison EP, Tovar C, Hsu A, Bender HS, Kheradpour P, et al., 'The Tasmanian Devil Transcriptome Reveals Schwann Cell Origins of a Clonally Transmissible Cancer ', Science, 327, (5961) pp. 84-87. ISSN 0036-8075 (2010) [Refereed Article] DOI: 10.1126/science.1180616 [eCite] [Details] Citations: Scopus - 177Web of Science - 160 Co-authors: Tovar C; Obendorf D; Blizzard CA; Kreiss A Tweet

Journal Article

(91 outputs)

Year	Citation	Altmetrics
2022	Espejo C, Patchett AL, Wilson R, Lyons AB, Woods GM, 'Challenges of an emerging disease: The evolving approach to diagnosing devil facial tumour disease', Pathogens, 11, (1) pp. 1-12. ISSN 2076-0817 (2022) [Refereed Article] DOI: 10.3390/pathogens11010027 [eCite] [Details] Co-authors: Espejo C; Patchett AL; Wilson R; Lyons AB Tweet
2022	Espejo C, Wilson R, Pye RJ, Ratcliffe JC, Ruiz-Aravena M, et al., 'Cathelicidin-3 associated with serum extracellular vesicles enables early diagnosis of a transmissible cancer', Frontiers in Immunology, 13 pp. 1-14. ISSN 1664-3224 (2022) [Refereed Article] DOI: 10.3389/fimmu.2022.858423 [eCite] [Details] Co-authors: Espejo C; Wilson R; Pye RJ; Ruiz-Aravena M; Wolfe BW; Hamede R; Lyons AB Tweet
2022	Ong CEB, Cheng V, Siddle HV, Lyons AB, Woods GM, et al., 'Class II transactivator induces expression of MHC-I and MHC-II in transmissible Tasmanian devil facial tumours', Open biology, 12, (10) Article 220208. ISSN 2046-2441 (2022) [Refereed Article] DOI: 10.1098/rsob.220208 [eCite] [Details] Citations: Scopus - 1 Co-authors: Ong CEB; Lyons AB; Flies AS Tweet
2021	Espejo C, Wilson R, Willms E, Ruiz-Aravena M, Pye RJ, et al., 'Extracellular vesicle proteomes of two transmissible cancers of Tasmanian devils reveal tenascin-C as a serum-based differential diagnostic biomarker', Cellular and Molecular Life Sciences, 78, (23) pp. 7537-7555. ISSN 1420-682X (2021) [Refereed Article] DOI: 10.1007/s00018-021-03955-y [eCite] [Details] Citations: Scopus - 5Web of Science - 5 Co-authors: Espejo C; Wilson R; Ruiz-Aravena M; Pye RJ; Jones M; Lyons AB Tweet
2021	Ong C, Patchett AL, Darby JM, Chen J, Liu G, et al., 'NLRC5 regulates expression of MHC-I and provides a target for anti-tumor immunity in 3 transmissible cancers', Journal of Cancer Research and Clinical Oncology, 147, (7) pp. 1973-1991. ISSN 0171-5216 (2021) [Refereed Article] DOI: 10.1101/2020.09.06.274720 [eCite] [Details] Citations: Scopus - 6Web of Science - 6 Co-authors: Ong C; Patchett AL; Darby JM; Liu G; Lyons AB; Flies AS Tweet
2021	Patchett AL, Tovar C, Blackburn NB, Woods GM, Lyons AB, 'Mesenchymal plasticity of devil facial tumour cells during in vivo vaccine and immunotherapy trials', Immunology and Cell Biology pp. 1-13. ISSN 0818-9641 (2021) [Refereed Article] DOI: 10.1111/imcb.12451 [eCite] [Details] Citations: Scopus - 4Web of Science - 5 Co-authors: Patchett AL; Tovar C; Blackburn NB; Lyons AB Tweet
2021	Pye RJ, Darby JM, Flies AS, Fox S, Carver SS, et al., 'Post-release immune responses of Tasmanian devils vaccinated with an experimental devil facial tumour disease vaccine', Wildlife Research, 48, (8) pp. 701-712. ISSN 1035-3712 (2021) [Refereed Article] DOI: 10.1071/WR20210 [eCite] [Details] Citations: Scopus - 2Web of Science - 2 Co-authors: Pye RJ; Darby JM; Flies AS; Carver SS; Lyons AB Tweet
2021	Wong C, Darby JM, Murphy PR, Pinfold TL, Lennard PR, et al., 'Tasmanian devil CD28 and CTLA4 capture CD80 and CD86 from adjacent cells', Developmental and Comparative Immunology, 115 Article 103882. ISSN 0145-305X (2021) [Refereed Article] DOI: 10.1016/j.dci.2020.103882 [eCite] [Details] Citations: Scopus - 3Web of Science - 3 Co-authors: Darby JM; Murphy PR; Pinfold TL; Lyons AB; Flies AS Tweet
2020	Flies AS, Darby JM, Lennard PR, Murphy PR, Ong C, et al., 'A novel system to map protein interactions reveals evolutionarily conserved immune evasion pathways on transmissible cancers', Science Advances, 6, (27) Article eaba5031. ISSN 2375-2548 (2020) [Refereed Article] DOI: 10.1126/sciadv.aba5031 [eCite] [Details] Citations: Scopus - 12Web of Science - 10 Co-authors: Flies AS; Darby JM; Lennard PR; Murphy PR; Ong C; Pinfold TL; De Luca A; Lyons AB; Patchett AL Tweet
2020	Kwon YM, Gori K, Park N, Potts N, Swift K, et al., 'Evolution and lineage dynamics of a transmissible cancer in Tasmanian devils', PLoS Biology, 18, (11) Article e3000926. ISSN 1544-9173 (2020) [Refereed Article] DOI: 10.1371/journal.pbio.3000926 [eCite] [Details] Citations: Scopus - 12Web of Science - 11 Co-authors: Comte S; Jones M; Kreiss A; Pye R; Hamede R Tweet
2020	Patchett AL, Flies AS, Lyons AB, Woods GM, 'Curse of the devil: molecular insights into the emergence of transmissible cancers in the Tasmanian devil (Sarcophilus harrisii)', Cellular and Molecular Life Sciences, 77, (13) pp. 2507-2525. ISSN 1420-682X (2020) [Refereed Article] DOI: 10.1007/s00018-019-03435-4 [eCite] [Details] Citations: Scopus - 9Web of Science - 10 Co-authors: Patchett AL; Flies AS; Lyons AB Tweet
2020	Woods GM, Lyons AB, Bettiol SS, 'A devil of a transmissible cancer', Tropical Medicine and Infectious Disease, 5, (2) Article 50. ISSN 2414-6366 (2020) [Refereed Article] DOI: 10.3390/tropicalmed5020050 [eCite] [Details] Citations: Scopus - 3Web of Science - 4 Co-authors: Lyons AB; Bettiol SS Tweet
2019	Flies AS, Woods GM, 'Editorial: Wild Immunology - The answers are out there', Frontiers in Immunology, 10 Article 126. ISSN 1664-3224 (2019) [Letter or Note in Journal] DOI: 10.3389/fimmu.2019.00126 [eCite] [Details] Citations: Scopus - 4Web of Science - 3 Co-authors: Flies AS Tweet
2019	James S, Jennings G, Kwon YM, Stammnitz M, Fraik A, et al., 'Tracing the rise of malignant cell lines: distribution, epidemiology and evolutionary interactions of two transmissible cancers in Tasmanian devils', Evolutionary Applications, 12, (9) pp. 1772-1780. ISSN 1752-4571 (2019) [Refereed Article] DOI: 10.1111/eva.12831 [eCite] [Details] Citations: Scopus - 22Web of Science - 19 Co-authors: James S; Jennings G; Comte S; Pye R; Lyons B; Jones M; Hamede R Tweet
2019	Kosack L, Wingelhofer B, Popa A, Orlova A, Agerer B, et al., 'The ERBB-STAT3 axis drives Tasmanian devil facial tumor disease', Cancer Cell, 35, (1) pp. 125-139. ISSN 1535-6108 (2019) [Refereed Article] DOI: 10.1016/j.ccell.2018.11.018 [eCite] [Details] Citations: Scopus - 30Web of Science - 29 Tweet
2019	Li X, Darby J, Lyons AB, Woods GM, Korner H, 'TNF may negatively regulate phagocytosis of Devil Facial Tumour Disease cells by activated macrophages', Immunological Investigations, 48, (7) pp. 691-703. ISSN 0882-0139 (2019) [Refereed Article] DOI: 10.1080/08820139.2018.1515222 [eCite] [Details] Citations: Scopus - 3Web of Science - 5 Co-authors: Darby J; Lyons AB; Korner H Tweet
2019	Ong C, Lyons AB, Woods GM, Flies AS, 'Inducible IFN-γ expression for MHC-I upregulation in devil facial tumor cells', Frontiers in Immunology, 9 Article 3117. ISSN 1664-3224 (2019) [Refereed Article] DOI: 10.3389/fimmu.2018.03117 [eCite] [Details] Citations: Scopus - 10Web of Science - 10 Co-authors: Ong C; Lyons AB; Flies AS Tweet
2019	Patchett AL, Coorens THH, Darby J, Wilson R, McKay MJ, et al., 'Two of a kind: transmissible Schwann cell cancers in the endangered Tasmanian devil (Sarcophilus harrisii)', Cellular and Molecular Life Sciences, 77 pp. 1847-1858. ISSN 1420-682X (2019) [Refereed Article] DOI: 10.1007/s00018-019-03259-2 [eCite] [Details] Citations: Scopus - 16Web of Science - 15 Co-authors: Patchett AL; Darby J; Wilson R; Pye RJ; Flies AS; Lyons AB; Tovar C Tweet
2018	Caldwell A, Coleby R, Tovar C, Stammnitz MR, Kwon YM, et al., 'The newly-arisen devil facial tumour disease 2 (DFT2) reveals a mechanism for the emergence of a contagious cancer', Elife, 7 Article e35314. ISSN 2050-084X (2018) [Refereed Article] DOI: 10.7554/eLife.35314 [eCite] [Details] Citations: Scopus - 31Web of Science - 32 Co-authors: Tovar C Tweet
2018	Chen L, Bennett E, Wheeler AJ, Lyons AB, Woods GM, et al., 'Maternal exposure to particulate matter alters early post-natal lung function and immune cell development', Environmental Research, 164 pp. 625-635. ISSN 0013-9351 (2018) [Refereed Article] DOI: 10.1016/j.envres.2018.03.029 [eCite] [Details] Citations: Scopus - 13Web of Science - 12 Co-authors: Chen L; Bennett E; Wheeler AJ; Lyons AB; Johnston F; Zosky GR Tweet
2018	Fernandez-Rojo MA, Deplazes E, Pineda SS, Brust A, Marth T, et al., 'Gomesin peptides prevent proliferation and lead to the cell death of devil facial tumour disease cells', Cell Death Discovery, 4 Article 19. ISSN 2058-7716 (2018) [Refereed Article] DOI: 10.1038/s41420-018-0030-0 [eCite] [Details] Citations: Scopus - 12Web of Science - 13 Tweet
2018	Patchett AL, Wilson R, Charlesworth JC, Corcoran LM, Papenfuss AT, et al., 'Transcriptome and proteome profiling reveals stress-induced expression signatures of imiquimod-treated Tasmanian devil facial tumor disease (DFTD) cells', OncoTarget, 9, (22) pp. 15895-15914. ISSN 1949-2553 (2018) [Refereed Article] DOI: 10.18632/oncotarget.24634 [eCite] [Details] Citations: Scopus - 9 Co-authors: Patchett AL; Wilson R; Charlesworth JC; Lyons AB; Tovar C Tweet
2018	Pye R, Patchett A, McLennan E, Thomson R, Carver S, et al., 'Immunization strategies producing a humoral IgG immune response against devil facial tumor disease in the majority of Tasmanian devils destined for wild release', Frontiers in Immunology, 9 Article 259. ISSN 1664-3224 (2018) [Refereed Article] DOI: 10.3389/fimmu.2018.00259 [eCite] [Details] Citations: Scopus - 23Web of Science - 25 Co-authors: Pye R; Patchett A; Carver S; Kreiss A; Lyons AB Tweet
2018	Stammnitz MR, Coorens THH, Gori KC, Hayes DA, Fu B, et al., 'The origins and vulnerabilities of two transmissible cancers in Tasmanian devils', Cancer Cell, 33, (4) Article e15. ISSN 1535-6108 (2018) [Refereed Article] DOI: 10.1016/j.ccell.2018.03.013 [eCite] [Details] Citations: Scopus - 56Web of Science - 57 Co-authors: Hayes DA; Pye RJ; Sohal SS Tweet
2018	Tovar C, Patchett AL, Kim V, Wilson R, Darby J, et al., 'Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour disease', PLoS ONE, 13, (4) Article e0196469. ISSN 1932-6203 (2018) [Refereed Article] DOI: 10.1371/journal.pone.0196469 [eCite] [Details] Citations: Scopus - 4Web of Science - 4 Co-authors: Tovar C; Patchett AL; Wilson R; Darby J; Lyons AB Tweet
2018	Woods GM, Fox S, Flies A, Tovar CD, Jones M, et al., 'Two decades of the impact of Tasmanian Devil Facial Tumour Disease (DFTD)', Integrative and Comparative Biology, 58, (6) pp. 1043-1054. ISSN 1540-7063 (2018) [Refereed Article] DOI: 10.1093/icb/icy118 [eCite] [Details] Citations: Scopus - 7Web of Science - 6 Co-authors: Flies A; Tovar CD; Jones M; Hamede R; Lyons AB; Bettiol S Tweet
2017	Flies AS, Blackburn NB, Lyons AB, Hayball JD, Woods GM, 'Comparative analysis of immune checkpoint molecules and their potential role in the transmissible Tasmanian Devil facial tumor disease', Frontiers in Immunology, 8 Article 513. ISSN 1664-3224 (2017) [Refereed Article] DOI: 10.3389/fimmu.2017.00513 [eCite] [Details] Citations: Scopus - 12Web of Science - 14 Co-authors: Flies AS; Blackburn NB; Lyons AB Tweet
2017	Li X, Lyons AB, Woods GM, Korner H, 'The absence of TNF permits myeloid Arginase 1 expression in experimental L. monocytogenes infection', Immunobiology, 222, (8-9) pp. 913-917. ISSN 0171-2985 (2017) [Refereed Article] DOI: 10.1016/j.imbio.2017.05.012 [eCite] [Details] Citations: Scopus - 9Web of Science - 7 Co-authors: Lyons AB; Korner H Tweet
2017	Patchett AL, Tovar C, Corcoran LM, Lyons AB, Woods GM, 'The toll-like receptor ligands Hiltonol^® (polyICLC) and imiquimod effectively activate antigen-specific immune responses in Tasmanian devils (Sarcophilus harrisii)', Developmental and Comparative Immunology, 76 pp. 352-360. ISSN 0145-305X (2017) [Refereed Article] DOI: 10.1016/j.dci.2017.07.004 [eCite] [Details] Citations: Scopus - 11Web of Science - 12 Co-authors: Patchett AL; Tovar C; Lyons AB Tweet
2017	Tovar C, Pye RJ, Kreiss A, Cheng Y, Brown GK, et al., 'Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devils', Scientific Reports, 7 Article 43827. ISSN 2045-2322 (2017) [Refereed Article] DOI: 10.1038/srep43827 [eCite] [Details] Citations: Scopus - 41Web of Science - 41 Co-authors: Tovar C; Pye RJ; Kreiss A; Brown GK; Darby J; Malley RC; Lyons AB Tweet
2016	Atashrazm F, Lowenthal RM, Dickinson JL, Holloway AF, Woods GM, 'Fucoidan enhances the therapeutic potential of arsenic trioxide and all-trans retinoic acid in acute promyelocytic leukemia, in vitro and in vivo', OncoTarget, 7, (29) pp. 46028-46041. ISSN 1949-2553 (2016) [Refereed Article] DOI: 10.18632/oncotarget.10016 [eCite] [Details] Citations: Scopus - 16Web of Science - 13 Co-authors: Lowenthal RM; Dickinson JL; Holloway AF Tweet
2016	Brown GK, Tovar C, Cooray AA, Kreiss A, Darby J, et al., 'Mitogen activated Tasmanian devil blood mononuclear cells kill devil facial tumour disease cells', Immunology and Cell Biology, 94, (7) pp. 673-679. ISSN 0818-9641 (2016) [Refereed Article] DOI: 10.1038/icb.2016.38 [eCite] [Details] Citations: Scopus - 17Web of Science - 17 Co-authors: Brown GK; Tovar C; Cooray AA; Kreiss A; Darby J; Bettiol SS; Lyons AB Tweet
2016	Flies AS, Lyons AB, Corcoran LM, Papenfuss AT, Murphy JM, et al., 'PD-L1 is not constitutively expressed on Tasmanian devil facial tumor cells but is strongly upregulated in response to IFN-γ and can be expressed in the tumor microenvironment', Frontiers in Immunology, 7 Article 581. ISSN 1664-3224 (2016) [Refereed Article] DOI: 10.3389/fimmu.2016.00581 [eCite] [Details] Citations: Scopus - 29Web of Science - 29 Co-authors: Flies AS; Lyons AB Tweet
2016	Karu N, Wilson R, Hamede R, Jones M, Woods GM, et al., 'Discovery of biomarkers for Tasmanian devil cancer (DFTD) by metabolic profiling of serum', Journal of Proteome Research, 15, (10) pp. 3827-3840. ISSN 1535-3907 (2016) [Refereed Article] DOI: 10.1021/acs.jproteome.6b00629 [eCite] [Details] Citations: Scopus - 12Web of Science - 12 Co-authors: Karu N; Wilson R; Hamede R; Jones M; Hilder EF; Shellie RA Tweet
2016	Patchett AL, Darby JM, Tovar C, Lyons AB, Woods GM, 'The immunomodulatory small molecule imiquimod induces apoptosis in devil facial tumour cell lines', PL o S One, 11, (12) Article e0168068. ISSN 1932-6203 (2016) [Refereed Article] DOI: 10.1371/journal.pone.0168068 [eCite] [Details] Citations: Scopus - 11Web of Science - 10 Co-authors: Patchett AL; Darby JM; Tovar C; Lyons AB Tweet
2016	Pye RJ, Hamede R, Siddle HV, Caldwell A, Knowles GW, et al., 'Demonstration of immune responses against devil facial tumour disease in wild Tasmanian devils', Biology Letters, 12, (10) Article 20160553. ISSN 1744-9561 (2016) [Refereed Article] DOI: 10.1098/rsbl.2016.0553 [eCite] [Details] Citations: Scopus - 61Web of Science - 60 Co-authors: Pye RJ; Hamede R; Kreiss A; Jones ME; Lyons AB Tweet
2016	Pye RJ, Woods GM, Kreiss A, 'Devil facial tumor disease', Veterinary Pathology, 53, (4) pp. 726-736. ISSN 0300-9858 (2016) [Refereed Article] DOI: 10.1177/0300985815616444 [eCite] [Details] Citations: Scopus - 14Web of Science - 13 Co-authors: Pye RJ; Kreiss A Tweet
2015	Atashrazm F, Lowenthal RM, Woods GM, Holloway AF, Dickinson JL, 'Fucoidan and cancer: a multifunctional molecule with anti-tumor potential', Marine Drugs, 13, (4) pp. 2327-2346. ISSN 1660-3397 (2015) [Refereed Article] DOI: 10.3390/md13042327 [eCite] [Details] Citations: Scopus - 200Web of Science - 187 Co-authors: Lowenthal RM; Holloway AF; Dickinson JL Tweet
2015	Atashrazm F, Lowenthal RM, Woods GM, Holloway AF, Karpiniec SS, et al., 'Fucoidan suppresses the growth of human acute promyelocytic leukemia cells in vitro and in vivo', Journal of Cellular Physiology, 231, (3) pp. 688-697. ISSN 0021-9541 (2015) [Refereed Article] DOI: 10.1002/jcp.25119 [eCite] [Details] Citations: Scopus - 32Web of Science - 30 Co-authors: Lowenthal RM; Holloway AF; Dickinson JL Tweet
2015	Kreiss A, Brown GK, Tovar C, Lyons AB, Woods GM, 'Evidence for induction of humoral and cytotoxic immune responses against devil facial tumor disease cells in Tasmanian devils (Sarcophilus harrisii) immunized with killed cell preparations', Vaccine, 33, (26) pp. 3016-3025. ISSN 0264-410X (2015) [Refereed Article] DOI: 10.1016/j.vaccine.2015.01.039 [eCite] [Details] Citations: Scopus - 40Web of Science - 36 Co-authors: Kreiss A; Brown GK; Tovar C; Lyons AB Tweet
2015	Patchett AL, Latham R, Brettingham-Moore KH, Tovar C, Lyons AB, et al., 'Toll-like receptor signaling is functional in immune cells of the endangered Tasmanian devil', Developmental and Comparative Immunology, 53 pp. 123-133. ISSN 0145-305X (2015) [Refereed Article] DOI: 10.1016/j.dci.2015.07.003 [eCite] [Details] Citations: Scopus - 15Web of Science - 14 Co-authors: Patchett AL; Latham R; Brettingham-Moore KH; Tovar C; Lyons AB Tweet
2015	Pye RJ, Pemberton D, Tovar C, Tubio JM, Dun KA, et al., 'A second transmissible cancer in Tasmanian devils', Proceedings of the National Academy of Sciences, 113, (2) pp. 374-379. ISSN 0027-8424 (2015) [Refereed Article] DOI: 10.1073/pnas.1519691113 [eCite] [Details] Citations: Scopus - 140Web of Science - 138 Co-authors: Pye RJ; Tovar C; Darby J; Kreiss A; Lyons AB Tweet
2015	Woods GM, Howson LJ, Brown GK, Tovar C, Kreiss A, et al., 'Immunology of a transmissible cancer spreading among Tasmanian devils', Journal of Immunology, 195, (1) pp. 23-29. ISSN 0022-1767 (2015) [Refereed Article] DOI: 10.4049/jimmunol.1500131 [eCite] [Details] Citations: Scopus - 19Web of Science - 19 Co-authors: Howson LJ; Brown GK; Tovar C; Kreiss A; Lyons AB Tweet
2014	Howson LJ, Morris KM, Kobayashi T, Tovar C, Kreiss A, et al., 'Identification of dendritic cells, B cell and T cell subsets in Tasmanian devil lymphoid tissue; evidence for poor immune cell infiltration into devil facial tumors', Anatomical Record, 297, (5) pp. 925-938. ISSN 1932-8486 (2014) [Refereed Article] DOI: 10.1002/ar.22904 [eCite] [Details] Citations: Scopus - 30Web of Science - 29 Co-authors: Howson LJ; Tovar C; Kreiss A Tweet
2014	Pinfold TL, Brown GK, Bettiol SS, Woods GM, 'Mouse Model of Devil Facial Tumour Disease Establishes That an Effective Immune Response Can be Generated Against the Cancer Cells', Frontiers in Immunology, 5 Article 251. ISSN 1664-3224 (2014) [Refereed Article] DOI: 10.3389/fimmu.2014.00251 [eCite] [Details] Citations: Scopus - 11Web of Science - 13 Co-authors: Pinfold TL; Brown GK; Bettiol SS Tweet
2013	Malley RC, Muller HK, Norval M, Woods GM, 'Dietary vitamin D alters the response of the skin to UVB-irradiation depending on the genetic background of the mice', Photochemical & Photobiological Sciences, 12 pp. 536-545. ISSN 1474-9092 (2013) [Refereed Article] DOI: 10.1039/c2pp25211b [eCite] [Details] Citations: Scopus - 12Web of Science - 10 Co-authors: Malley RC; Muller HK Tweet
2013	Siddle HV, Kreiss A, Tovar C, Yuen CK, Cheng Y, et al., 'Reversible epigenetic down-regulation of MHC molecules by devil facial tumour disease illustrates immune escape by a contagious cancer', Proceedings of the National Academy of Sciences of the United States of America, 110, (13) pp. 5103-5108. ISSN 0027-8424 (2013) [Refereed Article] DOI: 10.1073/pnas.1219920110 [eCite] [Details] Citations: Scopus - 1Web of Science - 151 Co-authors: Kreiss A; Tovar C; Hamede R; Jones ME Tweet
2012	Casey NP, Woods GM, 'Anti-PML-RARα shRNA sensitises promyelocytic leukaemia cells to all-trans retinoic acid', Journal of RNAi and Gene Silencing, 8 pp. 464-469. ISSN 1747-0854 (2012) [Refereed Article] PMID: 23300507 [eCite] [Details] Citations: Scopus - 1 Co-authors: Casey NP Tweet
2012	Hamede R, Lachish S, Belov K, Woods G, Kreiss A, et al., 'Reduced effect of Tasmanian devil facial tumor disease at the disease front', Conservation Biology, 26, (1) pp. 124-134. ISSN 0888-8892 (2012) [Refereed Article] DOI: 10.1111/j.1523-1739.2011.01747.x [eCite] [Details] Citations: Scopus - 55Web of Science - 58 Co-authors: Hamede R; Lachish S; Kreiss A; Jones M; McCallum H Tweet
2012	Murchison EP, Schulz-Trieglaff OB, Ning Z, Alexandrov LB, Bauer MJ, et al., 'Genome Sequencing and Analysis of the Tasmanian Devil and Its Transmissible Cancer', Cell, 148, (4) pp. 780-791. ISSN 0092-8674 (2012) [Refereed Article] DOI: 10.1016/j.cell.2011.11.065 [eCite] [Details] Citations: Scopus - 233Web of Science - 234 Co-authors: Kreiss A Tweet
2011	Brown GK, Kreiss A, Lyons AB, Woods GM, 'Natural Killer Cell Mediated Cytotoxic Responses in the Tasmanian Devil', PL o S One , 6, (9) Article e24475. ISSN 1932-6203 (2011) [Refereed Article] DOI: 10.1371/journal.pone.0024475 [eCite] [Details] Citations: Scopus - 38Web of Science - 36 Co-authors: Brown GK; Kreiss A; Lyons AB Tweet
2011	Dorantes Aranda JJ, Waite TD, Godrant A, Rose AL, Tovar CD, et al., 'Novel application of a fish gill cell line assay to assess ichthyotoxicity of harmful marine microalgae', Harmful Algae, 10, (4) pp. 366-373. ISSN 1568-9883 (2011) [Refereed Article] DOI: 10.1016/j.hal.2011.01.002 [eCite] [Details] Citations: Scopus - 46Web of Science - 45 Co-authors: Dorantes Aranda JJ; Tovar CD; Hallegraeff GM Tweet
2011	Kreiss A, Cheng Y, Kimble F, Wells B, Donovan S, et al., 'Allorecognition in the Tasmanian devil (Sarcophilus harrisii), an endangered marsupial species with limited genetic diversity', PL o S One, 6, (7) Article e22402. ISSN 1932-6203 (2011) [Refereed Article] DOI: 10.1371/journal.pone.0022402 [eCite] [Details] Citations: Scopus - 50Web of Science - 48 Co-authors: Kreiss A; Kimble F; Wells B Tweet
2011	Kreiss A, Tovar C, Obendorf DL, Dun K, Woods GM, 'A murine xenograft model for a transmissible cancer in Tasmanian devils', Veterinary Pathology, 48, (2) pp. 475-481. ISSN 0300-9858 (2011) [Refereed Article] DOI: 10.1177/0300985810380398 [eCite] [Details] Citations: Scopus - 21Web of Science - 19 Co-authors: Kreiss A; Tovar C; Obendorf DL Tweet
2011	McGee HM, Malley RC, Muller HK, Woods GM, 'Neonatal exposure to UVR alters skin immune system development, and suppresses immunity in adulthood', Immunology and Cell Biology, 89, (7) pp. 767-776. ISSN 0818-9641 (2011) [Refereed Article] DOI: 10.1038/icb.2010.170 [eCite] [Details] Citations: Scopus - 10Web of Science - 10 Co-authors: McGee HM; Malley RC; Muller HK Tweet
2011	Miller W, Hayes VM, Ratan A, Peterson DC, Wittekindt NE, et al., 'Genetic diversity and population structure of the endangered marsupial Sarcophilus harrisii (Tasmanian devil)', National Academy of Sciences of The United States of America. Proceedings, 108, (30) pp. 12348-12353. ISSN 0027-8424 (2011) [Refereed Article] DOI: 10.1073/pnas.1102838108 [eCite] [Details] Citations: Scopus - 160Web of Science - 151 Co-authors: Kreiss A; Jones ME Tweet
2011	Tovar C, Obendorf D, Murchison EP, Papenfuss AT, Kreiss A, et al., 'Tumor-specific diagnostic marker for transmissible facial tumors of Tasmanian devils: immunohistochemistry studies', Veterinary Pathology, 48, (6) pp. 1195-1203. ISSN 1544-2217 (2011) [Refereed Article] DOI: 10.1177/0300985811400447 [eCite] [Details] Citations: Scopus - 48Web of Science - 47 Co-authors: Tovar C; Obendorf D; Kreiss A Tweet
2010	Murchison EP, Tovar C, Hsu A, Bender HS, Kheradpour P, et al., 'The Tasmanian Devil Transcriptome Reveals Schwann Cell Origins of a Clonally Transmissible Cancer ', Science, 327, (5961) pp. 84-87. ISSN 0036-8075 (2010) [Refereed Article] DOI: 10.1126/science.1180616 [eCite] [Details] Citations: Scopus - 177Web of Science - 160 Co-authors: Tovar C; Obendorf D; Blizzard CA; Kreiss A Tweet
2009	Kreiss A, Obendorf DL, Hemsley S, Canfield PJ, Woods GM, 'A Histological and Immunohistochemical Analysis of Lymphoid Tissues of the Tasmanian Devil', The Anatomical Record, 292, (5) pp. 611-620. ISSN 1932-8486 (2009) [Refereed Article] DOI: 10.1002/ar.20896 [eCite] [Details] Citations: Scopus - 21Web of Science - 22 Co-authors: Kreiss A; Obendorf DL Tweet
2009	Kreiss A, Wells BB, Woods GM, 'The humoral immune response of the Tasmanian devil (Sarcophilus harrisii) against horse red blood cells ', Veterinary Immunology and Immunopathology: An International Journal of Comparative Immunology, 130, (1-2) pp. 135-137. ISSN 0165-2427 (2009) [Refereed Article] DOI: 10.1016/j.vetimm.2009.02.003 [eCite] [Details] Citations: Scopus - 20Web of Science - 18 Co-authors: Kreiss A; Wells BB Tweet
2009	Malley RC, Muller HK, Norval M, Woods GM, 'Vitamin D3 deficiency enhances contact hypersensitivity in male but not in female mice ', Cellular Immunology, 255, (1-2) pp. 33-40. ISSN 0008-8749 (2009) [Refereed Article] DOI: 10.1016/j.cellimm.2008.09.004 [eCite] [Details] Citations: Scopus - 13Web of Science - 13 Co-authors: Malley RC; Muller HK Tweet
2009	McGee HM, Dharmadasa T, Woods GM, 'Solar simulated ultraviolet radiation damages murine neonatal skin and alters Langerhans cell development, but does not induce inflammation', Photochemical & Photobiological Sciences, 8, (6) pp. 881-886. ISSN 1474-905X (2009) [Refereed Article] DOI: 10.1039/b822591e [eCite] [Details] Citations: Scopus - 3Web of Science - 2 Co-authors: McGee HM Tweet
2008	Kreiss A, Fox N, Bergfeld J, Quinn SJ, Pyecroft S, et al., 'Assessment of cellular immune responses of health and diseased Tasmanian devils (Sarcophilus harrisii)', Developmental & Comparative Immunology, 32, (5) pp. 544-553. ISSN 0145-305X (2008) [Refereed Article] DOI: 10.1016/j.dci.2007.09.002 [eCite] [Details] Citations: Scopus - 38Web of Science - 36 Co-authors: Kreiss A; Quinn SJ Tweet
2008	Muller HK, Malley RC, McGee HM, Scott DK, Wozniak T, et al., 'Effect of UV Radiation on the Neonatal Skin Immune System - Implicaions for Melanoma', Photochemistry and Photobiology, 84, (1) pp. 47-54. ISSN 0031-8655 (2008) [Refereed Article] DOI: 10.1111/j.1751-1097.2007.00246.x [eCite] [Details] Citations: Scopus - 21Web of Science - 21 Co-authors: Muller HK; Malley RC; McGee HM; Scott DK Tweet
2008	Stewart NJ, Bettiol SS, Kreiss A, Fox N, Woods GM, 'Mitogen-induced responses in lymphocytes from platypus, the Tasmanian devil and the eastern barred bandicoot', Australian Veterinary Journal, 86, (10) pp. 408-413. ISSN 0005-0423 (2008) [Refereed Article] DOI: 10.1111/j.1751-0813.2008.00349.x [eCite] [Details] Citations: Scopus - 8Web of Science - 6 Co-authors: Stewart NJ; Bettiol SS; Kreiss A Tweet
2007	Scott DK, Lord R, Muller HK, Malley RC, Woods GM, 'Proteomics identifies enhanced expression of stefin A in neonatal murine skin compared with adults: functional implications', British Journal of Dermatology, 156, (6) pp. 1156-1162. ISSN 0007-0963 (2007) [Refereed Article] DOI: 10.1111/j.1365-2133.2007.07875.x [eCite] [Details] Citations: Scopus - 19Web of Science - 20 Co-authors: Scott DK; Lord R; Muller HK; Malley RC Tweet
2007	Siddle HV, Kreiss A, Eldridge MDB, Noonan E, Clarke CJ, et al., 'Transmission of a fatal clonal tumor by biting occurs due to depleted MHC diversity in a threatened carnivorous marsupial', National Academy of Sciences Proceedings, 104, (41) pp. 16221-16226. ISSN 0027-8424 (2007) [Refereed Article] DOI: 10.1073/pnas.0704580104 [eCite] [Details] Citations: Scopus - 221Web of Science - 210 Co-authors: Kreiss A Tweet
2007	Stewart NJ, Taylor BVM, Ponsonby AL, Pittas F, Van der Mei IAF, et al., 'The effect of season on cytokine expression in multiple sclerosis and healthy subjects', Journal of Neuroimmunology, 188, (1-2) pp. 181-186. ISSN 0165-5728 (2007) [Refereed Article] DOI: 10.1016/j.jneuroim.2007.06.012 [eCite] [Details] Citations: Scopus - 23Web of Science - 22 Co-authors: Stewart NJ; Taylor BVM; Ponsonby AL; Pittas F; Van der Mei IAF; Walters EH Tweet
2007	Woods GM, Kreiss A, Bekov K, Siddle HV, Obendorf DL, et al., 'The Immune Response of the Tasmanian Devil (Sarcophilus harrisii) and Devil Facial Tumour Disease', EcoHealth, 4, (3) pp. 338-345. ISSN 1612-9202 (2007) [Refereed Article] DOI: 10.1007/s10393-007-0117-1 [eCite] [Details] Citations: Scopus - 64Web of Science - 54 Co-authors: Kreiss A; Obendorf DL; Muller HK Tweet
2006	McGee HM, Scott DK, Woods GM, 'Neonatal exposure to UV-B radiation leads to a large reduction in Langerhans cell density, but by maturity, there is an enhanced ability of dendritic cells to stimulate T cells', Immunology and Cell Biology, 84, (3) pp. 259-266. ISSN 0818-9641 (2006) [Refereed Article] DOI: 10.1111/j.1440-1711.2006.01429.x [eCite] [Details] Citations: Scopus - 9Web of Science - 9 Co-authors: McGee HM; Scott DK Tweet
2005	McLoone P, Woods GM, Norval M, 'Decrease in Langerhans Cells and Increase in Lymph Node Dendritic Cells Following Chronic Exposure of Mice to Suberythemal Doses of Solar Simulated Radiation', Photochemistry and Photobiology, 81, (5) pp. 1168-1173. ISSN 0031-8655 (2005) [Refereed Article] DOI: 10.1562/2005-04-10-RA-484 [eCite] [Details] Citations: Scopus - 27Web of Science - 24 Tweet
2005	Summers C, Norval M, De las Heras M, Gonzalez L, Sharp JM, et al., 'An influx of macrophages is the predominant local immune response in ovine pulmonary adenocarcinoma', Veterinary Immunology and Immunopathology, 106, (3-4) pp. 285-294. ISSN 0165-2427 (2005) [Refereed Article] DOI: 10.1016/j.vetimm.2005.03.006 [eCite] [Details] Citations: Scopus - 30Web of Science - 26 Tweet
2004	Brown SGA, Haas MA, Black A, Parameswaran A, Woods GM, et al., 'In vitro testing to diagnose venom allergy and monitor immunotherapy: a placebo-controlled, crossover trial', Clinical and Experimental Immunology, 34, (5) pp. 792-800. ISSN 0954-7894 (2004) [Refereed Article] DOI: 10.1111/j.1365-2222.2004.01949.x [eCite] [Details] Citations: Scopus - 20Web of Science - 22 Co-authors: Haas MA; Black A; Parameswaran A Tweet
2003	Bellette BM, Woods GM, Wozniak TM, Doherty KV, Muller HK, 'DEC-205^lo Langerin^lo neonatal Langerhans' cells preferentially utilize a wortmannin-sensitive, fluid-phase pathway to internalize exogenous antigen', Immunology, 110, (4) pp. 466-473. ISSN 0019-2805 (2003) [Refereed Article] DOI: 10.1111/j.1365-2567.2003.01759.x [eCite] [Details] Citations: Scopus - 15Web of Science - 14 Co-authors: Bellette BM; Wozniak TM; Doherty KV; Muller HK Tweet
2003	Simpson CC, Woods GM, Muller HK, 'Impaired CD40-signalling in Langerhans' cells from murine neonatal draining lymph nodes: implications for neonatally induced cutaneous tolerance', Clinical and Experimental Immunology, 132, (2) pp. 201-208. ISSN 0009-9104 (2003) [Refereed Article] DOI: 10.1046/j.1365-2249.2003.02154.x [eCite] [Details] Citations: Scopus - 21Web of Science - 18 Co-authors: Simpson CC; Muller HK Tweet
2003	Wronski E, Woods GM, Munday BL, 'Antibody response to sheep red blood cells in platypus and echidna', Comparative Biochemistry and Physiology. Part A: Molecular and Integrative Physiology, 136, (4) pp. 957-963. ISSN 1095-6433 (2003) [Refereed Article] DOI: 10.1016/S1095-6433(03)00325-8 [eCite] [Details] Citations: Scopus - 11Web of Science - 9 Co-authors: Wronski E; Munday BL Tweet
2002	Hearps AC, Burrows J, Connor CE, Woods GM, Lowenthal RM, et al., 'Mitochondrial cytochrome c release precedes transmembrane depolarisation and caspase-3 activation during ceramide-induced apoptosis of Jurkat T cells', Apoptosis, 7, (5) pp. 387-394. ISSN 1360-8185 (2002) [Refereed Article] DOI: 10.1023/A:1020034906200 [eCite] [Details] Citations: Scopus - 43Web of Science - 38 Co-authors: Hearps AC; Burrows J; Connor CE; Lowenthal RM; Ragg SJ Tweet
2001	Connor CE, Burrows J, Hearps AC, Woods GM, Lowenthal RM, et al., 'Cell Cycle Arrest of Hematopoietic Cell Lines After Treatment With Ceramide Is Commonly Associated With Retinoblastoma Activation', Cytometry, 43, (3) pp. 164-169. ISSN 0196-4763 (2001) [Refereed Article] DOI: 10.1002/1097-0320(20010301)43:3<164::AID-CYTO1044>3.0.CO;2-O [eCite] [Details] Citations: Scopus - 8Web of Science - 8 Co-authors: Connor CE; Burrows J; Hearps AC; Lowenthal RM; Ragg SJ Tweet
2001	Dewar AL, Doherty KV, Woods GM, Lyons AB, Muller HK, 'Acquisition of immune function during the development of the Langerhans cell network in neonatal mice', Immunology, 103, (1) pp. 61-69. ISSN 0019-2805 (2001) [Refereed Article] DOI: 10.1046/j.1365-2567.2001.01221.x [eCite] [Details] Citations: Scopus - 34Web of Science - 34 Co-authors: Doherty KV; Lyons AB; Muller HK Tweet
2001	Trambas CM, Wang Z, Cianfriglia M, Woods GM, 'Evidence that natural killer cells express mini P-glycoproteins but not classic 170 kDa P-glycoprotein', British Journal of Haematology, 114, (1) pp. 177-184. ISSN 0007-1048 (2001) [Refereed Article] DOI: 10.1046/j.1365-2141.2001.02885.x [eCite] [Details] Citations: Scopus - 33Web of Science - 28 Co-authors: Trambas CM Tweet
2001	Woods GM, Chen YP, Dewar AL, Doherty KV, Toh BH, et al., 'Prevention of Autoimmunity by Induction of Cutaneous Tolerance', Cellular Immunology, 207, (1) pp. 1-5. ISSN 0008-8749 (2001) [Refereed Article] DOI: 10.1006/cimm.2000.1733 [eCite] [Details] Citations: Scopus - 5Web of Science - 5 Co-authors: Doherty KV; Muller HK Tweet
2000	Woods GM, Doherty KV, Malley RC, Rist MJ, Muller HK, 'Carcinogen-modified dendritic cells induce immunosuppression by incomplete T-cell activation resulting from impaired antigen uptake and reduced CD86 expression', Immunology, 99, (1) pp. 16-22. ISSN 0019-2805 (2000) [Refereed Article] DOI: 10.1046/j.1365-2567.2000.00928.x [eCite] [Details] Citations: Scopus - 15Web of Science - 17 Co-authors: Doherty KV; Malley RC; Muller HK Tweet
1998	Chen YP, Muller HK, Scarff K, Toh BH, Woods GM, 'Induction of peripheral tolerance in neonatally thymectomized mice by immunization through chemical carcinogen-altered skin', Cellular Immunology, 189, (2) pp. 99-106. ISSN 0008-8749 (1998) [Refereed Article] DOI: 10.1006/cimm.1998.1370 [eCite] [Details] Citations: Scopus - 1Web of Science - 1 Co-authors: Muller HK Tweet
1997	Chen YP, Woods GM, Dandie GW, Muller HK, 'Down-regulation of an established immune response via chemical carcinogen or UVB-altered skin', Immunology and Cell Biology, 75, (3) pp. 238-244. ISSN 0818-9641 (1997) [Refereed Article] DOI: 10.1038/icb.1997.37 [eCite] [Details] Citations: Scopus - 3Web of Science - 3 Co-authors: Dandie GW; Muller HK Tweet
1997	Qu MM, Muller HK, Woods GM, 'Chemical carcinogens and antigens contribute to cutaneous tumor promotion by depleting epidermal Langerhans cells', Carcinogenesis, 18, (6) pp. 1277-1279. ISSN 0143-3334 (1997) [Refereed Article] DOI: 10.1093/carcin/18.6.1277 [eCite] [Details] Citations: Scopus - 20Web of Science - 16 Co-authors: Qu MM; Muller HK Tweet
1997	Ragg SJ, Woods GM, Egan PJ, Dandie GW, Muller HK, 'Failure of carcinogen-altered dendritic cells to initiate T cell proliferation is associated with reduced IL-1 beta secretion', Cellular Immunology, 178, (1) pp. 17-23. ISSN 0008-8749 (1997) [Refereed Article] DOI: 10.1006/cimm.1997.1110 [eCite] [Details] Citations: Scopus - 8Web of Science - 7 Co-authors: Ragg SJ; Dandie GW; Muller HK Tweet
1997	Trambas CM, Muller HK, Woods GM, 'P-glycoprotein mediated multidrug resistance and its implications for pathology', Pathology, 29, (2) pp. 122-130. ISSN 0031-3025 (1997) [Refereed Article] DOI: 10.1080/00313029700169734 [eCite] [Details] Citations: Scopus - 17Web of Science - 17 Co-authors: Trambas CM; Muller HK Tweet
1996	Woods GM, Qu MM, Ragg SJ, Muller HK, 'Chemical carcinogens and antigens induce immune suppression via Langerhans' cell depletion', Immunology, 88, (1) pp. 134-139. ISSN 0019-2805 (1996) [Refereed Article] DOI: 10.1046/j.1365-2567.1996.d01-645.x [eCite] [Details] Citations: Scopus - 19Web of Science - 19 Co-authors: Qu MM; Muller HK Tweet
1995	Ragg SJ, Dandie GW, Woods GM, Muller HK, 'Abrogation of afferent lymph dendritic cell function after cutaneously applied chemical carcinogens', Cellular Immunology, 162, (1) pp. 80-88. ISSN 0008-8749 (1995) [Refereed Article] DOI: 10.1006/cimm.1995.1054 [eCite] [Details] Citations: Scopus - 5Web of Science - 5 Co-authors: Dandie GW; Muller HK Tweet
1995	Trambas CM, Woods GM, 'Assessment of the available techniques for analysis of P-glycoprotein mediated multidrug resistance', Australian Journal of Medical Science, 16 pp. 143-146. ISSN 1038-1643 (1995) [Refereed Article] [eCite] [Details] Co-authors: Trambas CM
1995	Woods GM, Henderson KG, Qu MM, Muller HK, 'Processing of complex antigens and simple hapten-like molecules by epidermal Langerhans cells', Leukocyte Biology, 57, (6) pp. 891-896. ISSN 0741-5400 (1995) [Refereed Article] DOI: 10.1002/jlb.57.6.891 [eCite] [Details] Citations: Scopus - 7Web of Science - 5 Co-authors: Qu MM; Muller HK Tweet

Chapter in Book

(4 outputs)

Year	Citation	Altmetrics
2019	Lyons AB, Woods GM, 'Immune strategies to combat DFTD', Saving the Tasmanian Devil: Recovery through Science-based Management, CSIRO Publishing, C Hogg, S Fox, D Pemberton and K Belov (ed), Australia, pp. 77-84. ISBN 9781486307180 (2019) [Other Book Chapter] [eCite] [Details] Co-authors: Lyons AB
2013	Muller HK, Woods GM, 'Ultraviolet radiation effects on the proteome of skin cells', Advances in Experimental Medicine and Biology: Radiation Proteomics, Springer, D Leszczynski (ed), Dordrecht, Netherlands, pp. 111-119. ISBN 978-940075895-7 (2013) [Research Book Chapter] DOI: 10.1007/978-94-007-5896-4_8 [eCite] [Details] Citations: Web of Science - 16 Co-authors: Muller HK Tweet
2004	Muller HK, Halliday GM, Woods GM, 'The skin immune system and tumor immunosurveillance', The Skin Immune System, CRC Press, JD Bos (ed), Boca Raton, pp. 475-496. ISBN 0849319595 (2004) [Revised Book Chapter] [eCite] [Details] Co-authors: Muller HK
1997	Muller HK, Halliday GM, Woods GM, 'The skin immune system and immunosurveillance', Skin immune system (SIS), CRC Press, JD Bos (ed), Florida, pp. 719. ISBN 0-8493-4016-0 (1997) [Research Book Chapter] [eCite] [Details] Co-authors: Muller HK

Review

(10 outputs)

Year	Citation	Altmetrics
2019	Patchett A, Woods G, 'Targeting transmissible cancers in animals', Science, 365, (6452) pp. 438-440. ISSN 0036-8075 (2019) [Review Several Works] DOI: 10.1126/science.aau8936 [eCite] [Details] Citations: Scopus - 3Web of Science - 3 Co-authors: Patchett A Tweet
2011	Norval M, Woods GM, 'UV-induced immunosuppression and the efficacy of vaccination', Photochemical & Photobiological Sciences, 10, (8) pp. 1267-1274. (2011) [Review Several Works] DOI: 10.1039/c1pp05105a [eCite] [Details] Citations: Scopus - 30Web of Science - 22 Tweet
2010	McGee HM, Woods GM, Bennett B, Chung RS, 'The two faces of metallothionein in carcinogenesis: photoprotection against UVR-induced cancer and promotion of tumour survival', Photochemical & Photobiological Sciences, 9, (4) pp. 586-596. (2010) [Substantial Review] DOI: 10.1039/b9pp00155g [eCite] [Details] Citations: Scopus - 24Web of Science - 24 Co-authors: McGee HM; Bennett B; Chung RS Tweet
2008	Muller HK, Malley RC, McGee HM, Scott DK, Wozniak T, et al., 'Effect of UV Radiation on the Neonatal Skin Immune System- Implications for Melanoma', Photochemistry and Photobiology, 94, (1) pp. 47-54. (2008) [Review Several Works] DOI: 10.1111/j.1751-1097.2007.00246.x [eCite] [Details] Co-authors: Muller HK; Malley RC; McGee HM; Scott DK Tweet
2008	Norval M, Malley RC, Woods GM, 'What's new in photoimmunology?', Photodermatology, Photoimmunology & Photomedicine, 24, (6) pp. 334-336. (2008) [Review Several Works] [eCite] [Details] Co-authors: Malley RC
2008	Norval M, Woods GM, 'Comment on ''Hypothesis-Ultraviolet-B Irradiance and Vitamin D Reduce the Risk of Viral Infections and thus their Sequelae, Including Autoimmune Diseases and some Cancers'' by W.B. Grant, Photochem. Photobiol. (2007)', Photochemistry and Photobiology, 84 pp. 802-805. (2008) [Review Single Work] [eCite] [Details]
2007	Norval M, Malley RC, Woods GM, 'What's new in photoimmunology?', Photodermatology, Photoimmunology & Photomedicine, 23 pp. 148-151. (2007) [Review Several Works] [eCite] [Details] Co-authors: Malley RC
2007	Norval M, Malley RC, Woods GM, 'Immune protection against photocarcinogenesis', Expert Review of Dermatology, 2, (5) pp. 1507-1515. (2007) [Substantial Review] [eCite] [Details] Co-authors: Malley RC
2005	Norval M, Malley RC, Woods GM, 'What's new in photoimmunology', Photodermatology, Photoimmunology and Photomedicine, 21, (5) pp. 267-269. (2005) [Review Several Works] [eCite] [Details] Co-authors: Malley RC
2005	Woods GM, Malley RC, Muller HK, 'The skin immune system and the challenge of tumour immunosurveillance', European Journal of Dermatology, 157, (2) pp. 63-69. (2005) [Substantial Review] [eCite] [Details] Co-authors: Malley RC; Muller HK

Conference Publication

(91 outputs)

Year	Citation	Altmetrics
2017	Karu N, Patchett AL, Wilson R, Hamede Ross RK, Jones Menna, et al., 'Application of metabolomics and proteomics for biomarker discovery and development of therapies for the transmissible cancer, Tasmanian Devil Facial Tumour Disease', February 2nd-5th 2017, Lorne, VIC (2017) [Conference Edited] [eCite] [Details] Co-authors: Karu N; Patchett AL; Wilson R; Hamede Ross RK; Jones Menna; Lyons AB
2016	Karu N, Wilson RR, Hamede Ross RK, Jones Menna, Woods GM, et al., 'Discovery of serum biomarkers for Tasmanian Devil cancer (DFTD)', Proceedings of The Australian & New Zealand Metabolomics Conference, 31st March - 1st April, 2016, Melbourne, Australia (2016) [Conference Extract] [eCite] [Details] Co-authors: Karu N; Wilson RR; Hamede Ross RK; Jones Menna; Hilder EF; Shellie RA
2016	Patchett A, Pinfold T, Tovar C, Lyons B, Woods G, 'Abstract B040: Imiquimod initiates tumor specific overload of the ER stress response in Tasmanian devil facial cancer cells', Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: translating science into survival, September 25-28 2016, New York, NY (2016) [Conference Extract] DOI: 10.1158/2326-6066.IMM2016-B040 [eCite] [Details] Co-authors: Patchett A; Pinfold T; Tovar C; Lyons B Tweet
2016	Patchett AL, Kalodimos G, Tovar C, Lyons AB, Woods GM, 'Analysis of toll-like receptor responses in the endangered Tasmanian devil', International Congress of Immunology, August 21-26, 2016, Melbourne, Australia (2016) [Conference Extract] DOI: 10.1002/eji.201670200 [eCite] [Details] Co-authors: Patchett AL; Kalodimos G; Tovar C; Lyons AB Tweet
2015	Pinfold T, Brown GK, Patchett AL, Tovar CD, Bettiol SS, et al., 'Curse of the Devil: Devil Facial Tumour Disease', Australasian Cytometry Society 38th Annual Scientific Meeting, October 11-14, 2015, Perth, Australia (2015) [Conference Extract] [eCite] [Details] Co-authors: Pinfold T; Brown GK; Patchett AL; Tovar CD; Bettiol SS
2014	Tovar C, Pye RJ, Kreiss A, Woods G, 'The immune response of Tasmanian devils to devil facial tumour disease cell preparations', The 5th Australasian Vaccines & Immunotherapeutics Development Meeting, 7-9 May, Melbourne, Australia (2014) [Conference Extract] [eCite] [Details] Co-authors: Tovar C; Pye RJ; Kreiss A
2013	Pinfold T, Brown GK, Woods GM, 'Cancer from hell: Devil Facial Tumour Disease', 15th International Congress of Immunology, 22-27 August, 2013, Milan, Italy (2013) [Conference Extract] [eCite] [Details] Co-authors: Pinfold T; Brown GK
2010	Malley RC, Muller HK, Norval M, Woods GM, 'Vitamin D3, the skin immune system and cutaneous carcinogenesis', Report of the National Institute of Water and Atmospheric Research (NIWA) UV Workshop, 7-9 May, Queenstown, New Zealand, pp. 51. (2010) [Non Refereed Conference Paper] [eCite] [Details] Co-authors: Malley RC; Muller HK
2010	Malley RC, Muller HK, Woods GM, 'Vitamin D3 influences skin draining lymph node dendritic cells in neonatal male mice', National Health and Medical Research Congress, Melbourne, pp. 398. (2010) [Conference Extract] [eCite] [Details] Co-authors: Malley RC; Muller HK
2009	Kreiss A, Tovar C, Woods GM, 'Immunisation of Tasmanian devils (Sarcophilus harrisii) against Devil Facial Tumour Disease Tumour Cells', The 5th International Veterinary Vaccines and Diagnostics Conference, 19-23 July, Madison, USA (2009) [Conference Extract] [eCite] [Details] Co-authors: Kreiss A; Tovar C
2009	Kreiss A, Woods GM, 'Immunisation of Tasmanian Devils against Devil Facial Tumour Disease Tumour Cells', 58th Annual International Conference of the Wildlife Disease Association, August 2-7, Blaine, Washington (2009) [Conference Extract] [eCite] [Details] Co-authors: Kreiss A
2009	Malley RC, Muller HK, Woods GM, 'Dietary vitamin D3 protects against UVB-induced immunosuppression in C57BL/6, but not BALB/c mice', MEPSA Conference, Sydney (2009) [Conference Extract] [eCite] [Details] Co-authors: Malley RC; Muller HK
2008	Malley RC, Muller HK, Woods GM, 'Vitamin D3 nutrition influences regulatory T cell induction in neonatal tolerance and adult immunity', MEPSA Conference, December, Brisbane (2008) [Conference Extract] [eCite] [Details] Co-authors: Malley RC; Muller HK
2007	Bettiol SS, Ragg SJ, Woods GM, 'Catering to Student Demand: Bridging the Gap between Academics and Practicing Health Professionals', Improving University Teaching, Jaen, Spain (2007) [Conference Extract] [eCite] [Details] Co-authors: Bettiol SS; Ragg SJ
2007	Kreiss A, Woods GM, 'The immune responses of the Tasmanian devil (Sarcophilus harrisii) and the Devil Facial Tumour Disease', Proceedings of the 8th International Veterinary Immunology Symposium, 15-19 August, Ouro Preto, Brazil (2007) [Conference Extract] [eCite] [Details] Co-authors: Kreiss A
2007	Kreiss A, Woods GM, 'The humoral immune response of the Tasmanian devil (Sarcophilus harrisii) against two cellular antigens', 37th Annual Scientific Meeting for the Australasian Society for Immunology, Manly, Sydney (2007) [Conference Extract] [eCite] [Details] Co-authors: Kreiss A
2007	Kreiss A, Woods GM, 'The humoral immune response of the Tasmanian devil (Sarcophilus harrisii) against two cellular antigens', Proceedings of the International Congress of Immunology, Rio de Janeiro, Brazil (2007) [Conference Extract] [eCite] [Details] Co-authors: Kreiss A
2007	Malley RC, Muller HK, Woods GM, 'Dietary vitamin D3 influences UVB induced DNA damage and immunosuppression', Mutagenesis and Experimental Pathology of Australasia Conference, Hobart (2007) [Conference Extract] [eCite] [Details] Co-authors: Malley RC; Muller HK
2007	Malley RC, Muller HK, Woods GM, 'Vitamin D promotes neonatal tolerance induction to contact sensitisers', Australasian Society for Immunology Meeting, Sydney (2007) [Conference Extract] [eCite] [Details] Co-authors: Malley RC; Muller HK
2006	Dharmadasa T, Malley RC, Muller HK, Woods GM, 'Dietary Vitamin D3 deficiency alters skin UVB-induced DNA damage in neonatal mice', Proceedings of the Australian Health and Medical Research Congress 2006, November, 2006, Melbourne, Victoria, pp. 466. (2006) [Conference Extract] [eCite] [Details] Co-authors: Malley RC; Muller HK
2006	Kreiss A, Clarke C, Woods GM, 'Impaired allogeneic recognition may account for establishment of Devi Facial Tumour disease cells in Tasmanian devils', Proceedings of the Australian Health and Medical Research Congress 2006, November, 2006, Melbourne, Victoria, pp. 378. (2006) [Conference Extract] [eCite] [Details] Co-authors: Kreiss A; Clarke C
2006	Kreiss A, Woods GM, 'Mitogen induced lymphocyte proliferation and mixed lymphocyte reaction in Tasmanian devils (Sarcophilus harrisii)', Proceedings of the Australasian Society for Immunology, December, 2006, Auckland, New Zealand (2006) [Conference Extract] [eCite] [Details] Co-authors: Kreiss A
2006	Malley RC, Muller HK, Woods GM, 'Modification of skin immune system function by dietary vitamin D3 is influenced by age and gender', Proceedings of the Australian Health and Medical Research Congress 2006, November, 2006, Melbourne, Victoria, pp. 218. (2006) [Conference Extract] [eCite] [Details] Co-authors: Malley RC; Muller HK
2006	McGee HM, Woods GM, 'Neonatal exposure to solar simulated radiation alters development of skin immune system, resulting in long-term changes in lymph node cell populations', Proceedings of the Australian Health and Medical Research Congress 2006, November, 2006, Melbourne, Victoria, pp. 274. (2006) [Conference Extract] [eCite] [Details] Co-authors: McGee HM
2006	Woods GM, Kreiss A, 'Immune response of the Tasmanian devil', Proceedings of the Australian Health and Medical Research Congress 2006, November, 2006, Melbourne, Victoria, pp. 304. (2006) [Conference Extract] [eCite] [Details] Co-authors: Kreiss A
2006	Wright N, Wotherspoon SJ, Woods GM, Lowenthal RM, Ragg S, 'Reducing the toxicity of autologous stem cell transplants', Annual Scientific Meeting Handbook, 15-18 October 2006, Hobart, pp. 95. (2006) [Conference Extract] [eCite] [Details] Co-authors: Wotherspoon SJ; Lowenthal RM
2005	Kalodimos G, Muller HK, Feltis BN, Woods GM, 'The role of mast cells in neonatally induced suppression', Tissue Antigens, November, 2005, Melbourne, Victoria, pp. 458. ISSN 0001-2815 (2005) [Conference Extract] [eCite] [Details] Co-authors: Kalodimos G; Muller HK; Feltis BN
2005	Malley RC, Muller HK, Woods GM, 'Vitamin D deficiency alters the contact sensitivity response in BALB/c mice', Tissue Antigens, November, 2005, Melbourne, Victoria, pp. 486. ISSN 0001-2815 (2005) [Conference Extract] [eCite] [Details] Co-authors: Malley RC; Muller HK
2005	McGee HM, Woods GM, 'Neonatal Langerhans cell are more susceptible to ultraviolet radiation than adult Langerhans cells', Tissue Antigens, November, 2005, Melbourne, Victoria, pp. 491. ISSN 0001-2815 (2005) [Conference Extract] [eCite] [Details] Co-authors: McGee HM
2005	Scott DK, Lord RJ, Muller HK, Woods GM, 'Proteomics identifies enhanced expression of stefinA in neonatal murine skin compared to adult skin: Functional implications', Tissue Antigens, November, 2005, Melbourne, Victoria, pp. 537. ISSN 0001-2815 (2005) [Conference Extract] [eCite] [Details] Co-authors: Scott DK; Lord RJ; Muller HK
2005	Woods GM, Bellette BM, Kalodimos G, Muller HK, 'Poverty of inflammation in neonatal skin', Inflammation Research, August, 2005, Melbourne, Victoria, pp. S166. (2005) [Conference Extract] [eCite] [Details] Co-authors: Bellette BM; Kalodimos G; Muller HK
2005	Woods GM, Bellette BM, Scott DK, Muller HK, 'Neonatal Langerhans cells process, but do not effectively present, antigen resulting in impaired immunity', Abstracts of the 9th International workshop on Langerhans cells, September, 2005, Medeira, Portugal, pp. 90-91. (2005) [Conference Extract] [eCite] [Details] Co-authors: Bellette BM; Scott DK; Muller HK
2001	Bellette BM, Woods GM, Muller HK, 'Altered kinetics of antigen uptake by neonatal Langerhans cell: Implications for tolerance induction', Natural Products Which Modulate Tissue Repair, 29-30 November, Sydney, pp. 12. (2001) [Conference Extract] [eCite] [Details] Co-authors: Bellette BM; Muller HK
2001	Connor C, Burrows J, Woods GM, Ragg SJ, 'Ceramide activates the retinoblastoma protein via two independent mechanisms and induces maturation of human leukaemia cells', Abstract, 8-11th February 2001, Lorne Victoria (2001) [Conference Extract] [eCite] [Details] Co-authors: Connor C; Burrows J; Ragg SJ
2001	Jongbloed SL, Trambas CM, Woods GM, 'Non-apoptotic death of activated NK cells', Proceedings of the 31st Annual Meeting of the Australasian Society for Immunology, 2-6 December, Canberra, pp. 79. (2001) [Conference Extract] [eCite] [Details] Co-authors: Jongbloed SL; Trambas CM
2001	Jongbloed SL, Trambas CM, Woods GM, 'Non-apoptotic activation induced cell death of NK cells', Scandinavian Journal of Immunology, 22-27 July, Stockholm, Sweden, pp. Thu-17. ISSN 0301-6323 (2001) [Conference Extract] [eCite] [Details] Co-authors: Jongbloed SL; Trambas CM
2001	Muller HK, Doherty KV, Dewar AL, Chen YP, Toh BH, et al., 'Immature Langerhans cells: Central role in tolerance induction in carcinogen-treated and neonatal skin', Journal of Investigative Dermatology, 7-9 September, Stresa, Italy, pp. 1010. ISSN 0022-202X (2001) [Conference Extract] [eCite] [Details] Co-authors: Muller HK; Doherty KV
2001	Ng W, Doherty KV, Muller HK, Woods GM, 'Antigen induced maturation of neonatal Langerhans cells', Scandinavian Journal of Immunology, 22-27 July, Stockholm, Sweden, pp. Thu - 30. ISSN 0301-6323 (2001) [Conference Extract] [eCite] [Details] Co-authors: Doherty KV; Muller HK
2001	Trambas CM, Wang Z, Woods GM, 'Expression of mini-P-glycoprotein but not classical P-glycoprotein in human natural killer cells', Scandinavian Journal of Immunology, 22-27 July, Stockholm, Sweden, pp. Wed - 78. ISSN 0301-6323 (2001) [Conference Extract] [eCite] [Details] Co-authors: Trambas CM
2001	Woods GM, 'Session Co-chair', Proceedings of the 31st Annual Meeting of the Australasian Society for Immunology, 2-6 December, Canberra, pp. 77-78. (2001) [Chair National Conference] [eCite] [Details]
2001	Wozniak TM, Woods GM, Muller HK, 'Delayed immune response during neonatal development: A link between phenotype and function', Proceedings of the 31st Annual Meeting of the Australasian Society for Immunology, 2-6 December, Canberra, pp. 51. (2001) [Conference Extract] [eCite] [Details] Co-authors: Wozniak TM; Muller HK
2000	Doherty KV, Dewar AL, Woods GM, Muller HK, 'Are Recent Cell Immigrants to Adult Skin the Functional Correlate of Neonatal Cells?', 6th International Symposium on Dendritic Cells, 26 May - 1 June, Port Douglas, pp. 126. (2000) [Conference Extract] [eCite] [Details] Co-authors: Doherty KV; Muller HK
2000	Marsden VS, Woods GM, Trambas CM, Muller HK, 'Expression of P-glycoprotein by Dendritic Cells is not Required for Function', 6th International Symposium on Dendritic Cells, 26 May - 1 June, Port Douglas, pp. 74. (2000) [Conference Extract] [eCite] [Details] Co-authors: Trambas CM; Muller HK
2000	Trambas CM, Wang Z, Woods GM, 'Expression if Small Molecular Weight P-glycoprotein in NK Cells and Association with Restricted Transport Function', The 18th Natural Killer Cell Workshop, 5-9 May, 2000, Marseille, France, pp. IX-12. (2000) [Conference Extract] [eCite] [Details] Co-authors: Trambas CM
2000	Woods GM, Chen YP, Doherty KV, Toh BH, Muller HK, 'Protection Against Autoimmune Disease by Immunisation Through Skin Containing Immature Langerhans Cells', 6th International Symposium on Dendritic Cells, 26 May - 1 June, Port Douglas, pp. 127. (2000) [Conference Extract] [eCite] [Details] Co-authors: Doherty KV; Muller HK
1999	Bellette BM, Doherty KV, Woods GM, Muller HK, 'Modulation of Langerhans cell function: A role for antigen dose', 38th National Scientific Conference of the Australian Society for Medical Research, 27-29/11/1999, Leura, NSW, pp. 1. (1999) [Conference Extract] [eCite] [Details] Co-authors: Bellette BM; Doherty KV; Muller HK
1999	Connor CE, Woods GM, Lowenthal RM, Ragg SJ, 'Induction of p121CIP1 expression and retinoblastoma activation by ceramide in leukaemia cells', Signalling for life and death: cytometry in analysis and modelling of cell signalling, 18-21/7/1999, Hamilton Island, Australia, pp. 63. (1999) [Conference Extract] [eCite] [Details] Co-authors: Connor CE; Lowenthal RM; Ragg SJ
1999	Connor CE, Woods GM, Lowenthal RM, Ragg SJ, 'Induction of p121CIP1 expression and retinoblastoma activation by ceramide in leukaemia cells', Signalling for life and death: cytometry in analysis and modelling of cell signalling, 18-21/7/1999, Hamilton Island, Australia, pp. 63. (1999) [Conference Extract] [eCite] [Details] Co-authors: Connor CE; Lowenthal RM; Ragg SJ
1999	Dewar AL, Doherty KV, Woods GM, Muller HK, 'Neonatal Langerhans cells and maturation of antigen presenting cells', 6th International Workshop on Langerhans cells, 8-10/10/1999, New York, USA, pp. 45. (1999) [Conference Extract] [eCite] [Details] Co-authors: Doherty KV; Muller HK
1999	Dewar AL, Doherty KV, Woods GM, Muller HK, 'Maturation of antigen presenting cell function in neonatal Langerhans cells', 1st Annual Meeting of the Haematology Society of Australia and New Zealand, 17-10/10/1999, Hobart, Tasmania, pp. 182. (1999) [Conference Extract] [eCite] [Details] Co-authors: Doherty KV; Muller HK
1999	Doherty KV, Becker HE, Trambas CM, Woods GM, Muller HK, 'Fluorescent probes lack specificity for functional P-glycoprotein detection', 38th National Scientific Conference of the Australian Society for Medical Research, 27-29/11/1999, Leura, NSW, pp. poster 1-9. (1999) [Conference Extract] [eCite] [Details] Co-authors: Doherty KV; Trambas CM; Muller HK
1999	Doherty KV, Dewar AL, Woods GM, Muller HK, 'Carcinogen induced Langerhans cells: the functional correlate of neonatal Langerhans cells?', 38th National Scientific Conference of the Australian Society for Medical Research, 27-29/11/1999, Leura, NSW, pp. poster 1-8. (1999) [Conference Extract] [eCite] [Details] Co-authors: Doherty KV; Muller HK
1999	Marsden VS, Trambas CM, Woods GM, Muller HK, 'Is P-glycoprotein involved in Langerhans cell function?', 38th National Scientific Conference of the Australian Society for Medical Research, 27-29/11/1999, Leura, NSW, pp. poster 1-10. (1999) [Conference Extract] [eCite] [Details] Co-authors: Trambas CM; Muller HK
1999	Woods GM, Chen YP, Doherty KV, Dewar AL, Toh BH, et al., 'Modification of dendritic cell function -Implications for autoimmunity', 1st Annual Meeting of the Haematology Society of Australia and New Zealand, 17-10/10/1999, Hobart, Tasmania, pp. 169. (1999) [Conference Extract] [eCite] [Details] Co-authors: Doherty KV; Muller HK
1998	Dewar AL, Doherty KV, Woods GM, Muller HK, 'Neonatal Langerhans cells are defective in uptake and presentation of antigen and induce immunosuppression', 37th Annual Meeting of the Australian Society for Medical Research, 22-25 November, Hobart, Tasmania, pp. 70. (1998) [Conference Extract] [eCite] [Details] Co-authors: Doherty KV; Muller HK
1998	Dewar AL, Doherty KV, Woods GM, Muller HK, 'Neonatal Langerhans cells induce antigen specific suppression', 28th Annual meeting of the Australasian Society for Immunology, 29 November - 4 December, Melbourne, Victoria, pp. poster 5-10. (1998) [Conference Extract] [eCite] [Details] Co-authors: Doherty KV; Muller HK
1998	Doherty KV, Woods GM, Muller HK, 'Presentation by antigen following topical DMBA treatment is mediated by newly arrived Langerhans cells', 28th Annual meeting of the Australasian Society for Immunology, 29 November - 4 December, Melbourne, Victoria, pp. 1. (1998) [Conference Extract] [eCite] [Details] Co-authors: Doherty KV; Muller HK
1998	Doherty KV, Woods GM, Muller HK, 'Recent immigrants to the skin present antigen following carcinogen treatment', 37th Annual Meeting of the Australian Society for Medical Research, 22-25 November, Hobart, Tasmania, pp. 56. (1998) [Conference Extract] [eCite] [Details] Co-authors: Doherty KV; Muller HK
1998	Doherty KV, Woods GM, Muller HK, 'After cutaneous DMBA treatment, newly arrived Langerhans cells induce antigen specific immunosuppression', Journal of Leukocyte Biology, September 23-28, Pittsburgh, USA, pp. 90. (1998) [Conference Extract] [eCite] [Details] Co-authors: Doherty KV; Muller HK
1998	Muller HK, Malley RC, Woods GM, 'Alterations of Langerhans cell function during the early stages of cutaneous carcinogenesis confers immunosuppression rather than immunity', Journal of Investigative Dermatology, 7-10 May, Cologne, Germany, pp. 565. (1998) [Conference Extract] [eCite] [Details] Co-authors: Muller HK; Malley RC
1998	Rist MJ, Woods GM, Muller HK, 'Characterisation of carcinogen induced regulatory effector cells', 37th Annual Meeting of the Australian Society for Medical Research, 22-25 November, Hobart, Tasmania, pp. 70. (1998) [Conference Extract] [eCite] [Details] Co-authors: Muller HK
1998	Rist MJ, Woods GM, Muller HK, 'Analysis of migrating epidermal dendritic cells in carcinogen and contact sensitiser induced immunosuppression', 28th Annual meeting of the Australasian Society for Immunology, 29 November - 4 December, Melbourne, Victoria, pp. poster 5-60. (1998) [Conference Extract] [eCite] [Details] Co-authors: Muller HK
1998	Rist MJ, Woods GM, Muller HK, 'Phenotypic analysis of migrating epidermal dendritic cells in carcinogen and contact sensitiser induced immunosuppression', Journal of Leukocyte Biology, September 23-28, Pittsburgh, USA, pp. 90. (1998) [Conference Extract] [eCite] [Details] Co-authors: Muller HK
1998	Trambas CM, Woods GM, 'Detection of a novel P-glycoprotein conformation in drug-sensitive cells', 37th Annual Meeting of the Australian Society for Medical Research, 22-25 November, Hobart, Tasmania, pp. 43. (1998) [Conference Extract] [eCite] [Details] Co-authors: Trambas CM
1998	Trambas CM, Woods GM, 'Regulation and function of P-glycoprotein in human natural killer cells', 28th Annual meeting of the Australasian Society for Immunology, 29 November - 4 December, Melbourne, Victoria, pp. symposium 19-61. (1998) [Conference Extract] [eCite] [Details] Co-authors: Trambas CM
1998	Woods GM, 'Immunology/Inflammation', 37th National Scientific Conference of the Australian Society for Immunology, 22-25 November, Hobart, Tasmania, pp. Oral 13. (1998) [Chair National Conference] [eCite] [Details]
1998	Woods GM, Chen YP, Doherty KV, Toh BH, Muller HK, 'Modifying skin immunity', 37th Annual Meeting of the Australian Society for Medical Research, 22-25 November, Hobart, Tasmania, pp. 34. (1998) [Conference Extract] [eCite] [Details] Co-authors: Doherty KV; Muller HK
1997	Malley RC, Muller HK, Woods GM, 'Reduced dendritic cell function during the early stages of chemical carcinogenesis', 27th Annual Meeting of the Australasian Society for Immunology, Perth, pp. 68. (1997) [Conference Extract] [eCite] [Details] Co-authors: Malley RC; Muller HK
1997	Malley RC, Woods GM, Muller HK, 'Langerhans cell function during the early stages of carcinogenesis', 5th International Workshop on Langerhans cells, Salzburg, Vienna, pp. 268. (1997) [Conference Extract] [eCite] [Details] Co-authors: Malley RC; Muller HK
1997	Rist MJ, Woods GM, Muller HK, 'Antigen specific suppression in cutaneous carcinogenesis', Joint Meeting of the Australian and New Zealand Environmental Mutagen Society and the Australasian Society for Experimental Pathology, Mt. Buller, Victoria, pp. 21. (1997) [Conference Extract] [eCite] [Details] Co-authors: Muller HK
1997	Trambas CM, Woods GM, 'Selective involvement of P-glycoprotein in the granule pathway of cell mediated cytotoxicity', 27th Annual Meeting of the Australasian Society for Immunology, Perth, pp. 91. (1997) [Conference Extract] [eCite] [Details] Co-authors: Trambas CM
1997	Woods GM, 'Alterations of Langerhans cell function during the early stages of cutaneous carcinogenesis', 27th Annual Meeting of the Australasian Society for Immunology, Perth, pp. 37. (1997) [Conference Extract] [eCite] [Details]
1996	Chen YP, Woods GM, Scarff K, Toh BH, Muller HK, 'Cutaneous tolerance -- A potential strategy for treatment of autoimmune disease', Federation of Immunological Societies of Asia-Oceania, Adelaide, pp. 104. (1996) [Conference Extract] [eCite] [Details] Co-authors: Muller HK
1996	Muller HK, Chen YP, Dandie GW, Woods GM, 'Downregulation of immune responses by modified dendritic cells', Proceedings of the Australasian Society for Experimental Pathology Conference, Sydney, pp. 23. (1996) [Conference Extract] [eCite] [Details] Co-authors: Muller HK; Dandie GW
1996	Muller HK, Dandie GW, Woods GM, 'UV-B-induced immune suppression: implications for infection', The health consequences of ozone depletion, Hobart, pp. 225-229. (1996) [Non Refereed Conference Paper] [eCite] [Details] Co-authors: Muller HK; Dandie GW
1996	Woods GM, Qu MM, Muller HK, 'Langerhans cell depletion is a key component of cutaneous tumour promotion', Federation of Immunological Societies of Asia-Oceania, Adelaide, pp. 69. (1996) [Conference Extract] [eCite] [Details] Co-authors: Qu MM; Muller HK
1995	Chen YP, Woods GM, Dandie GW, Muller HK, 'Downregulation of an established immune response - a possible tactic for the treatment of autoimmune disease', Australasian Society for Immunology - Annual Conference, Gold Coast, Queensland, pp. 111. (1995) [Conference Extract] [eCite] [Details] Co-authors: Dandie GW; Muller HK
1995	Chen YP, Woods GM, Scarff K, Toh BH, Muller HK, 'Antigen presentation by modified dendritic cells as a strategy to down regulate autoimmunity', 4th International Workshop on the Molecular and Cell Biology of Autoantibodies and Autoimmunity, Melbourne, pp. 76. (1995) [Conference Extract] [eCite] [Details] Co-authors: Muller HK
1995	Field CM, Burges-Watson IP, Quinn D, Woods GM, Muller HK, 'Does combat-related post-traumatic stress disorder have a unique effect on immune responses?', Australasian Society for Immunology Annual Scientific Meeting, Gold Coast, Queensland, pp. 125. (1995) [Conference Extract] [eCite] [Details] Co-authors: Quinn D; Muller HK
1995	Gabrilovich DI, Patterson S, Harvey JJ, Woods GM, Elsley W, et al., 'Defects in the function of dendritic cells in murine retroviral infection', Dendritic cells in fundamental and clinical immunology, Annecy, France, pp. 469-472. (1995) [Non Refereed Conference Paper] [eCite] [Details]
1995	Muller HK, Ragg SJ, Chilcott AR, Grzegorczck AD, Dandie GW, et al., 'Langerhans cell function during carcinogen induced immunosuppression', Langerhans Cells, 4th International Workshop, Scheveningen, The Netherlands, pp. 862. (1995) [Conference Extract] [eCite] [Details] Co-authors: Muller HK; Chilcott AR; Dandie GW
1995	Muller HK, Ragg SJ, Dandie GW, Woods GM, 'Langerhans cell function during carcinogenesis', Australasian Society for Experimental Pathology, Auckland, New Zealand, pp. 18. (1995) [Conference Extract] [eCite] [Details] Co-authors: Muller HK; Dandie GW
1995	Ragg SJ, Dandie GW, Woods GM, Muller HK, 'Dendritic cells migrating from carcinogen-treated skin have reduced antigen-presenting function', Dendritic cells in fundamental and clinical immunology, Annecy, France, pp. 237-241. (1995) [Non Refereed Conference Paper] [eCite] [Details] Co-authors: Dandie GW; Muller HK
1995	Ragg SJ, Woods GM, Muller HK, 'Failure of carcinogen-altered dendritic cells to initiate T cell proliferation is associated with reduced IL-1B secretion', 9th International Congress of Immunology, San Francisco, USA, pp. 64. (1995) [Conference Extract] [eCite] [Details] Co-authors: Muller HK
1995	Rist MJ, Woods GM, Muller HK, 'Phenotype of migrating murine antigen presenting cells in cutaneous carcinogenesis', Australasian Society for Immunology Annual Scientific Meeting, Gold Coast, Queensland, pp. 55. (1995) [Conference Extract] [eCite] [Details] Co-authors: Muller HK
1995	Rist MJ, Woods GM, Muller HK, 'Phenotypic analysis of migrating murine antigen presenting cells in a model of cutaneous carcinogenesis', Australasian Flow Cytometry Group 18th Annual Meeting, Hobart, Tasmania, pp. no number. (1995) [Conference Extract] [eCite] [Details] Co-authors: Muller HK
1995	Trambas CM, Muller HK, Woods GM, 'Multidrug resistance and resistance to natural killer cells', 9th International Congress of Immunology, San Francisco, USA, pp. 483. (1995) [Conference Extract] [eCite] [Details] Co-authors: Trambas CM; Muller HK
1995	Trambas CM, Woods GM, 'P-Glycoprotein is involved in the secretion of cytotoxic factors during the terminal stage of natural killer cell cytotoxicity', Australasian Society for Immunology Annual Scientific Meeting, Gold Coast, Queensland, pp. 59. (1995) [Conference Extract] [eCite] [Details] Co-authors: Trambas CM
1995	Woods GM, 'Apoptosis, Cancer and Oncogenes', Medical Oncology Group of Australia inc. Mid Year Meeting, Cradle Mountain, Tasmania, pp. 24. (1995) [Conference Extract] [eCite] [Details]
1995	Woods GM, Gabrilovich DI, Elsley W, English N, Knight S, 'Dendritic cells, apoptosis and murine retrovirus', Dendritic cells in fundamental and clinical immunology, Annecy, France, pp. 493-496. (1995) [Non Refereed Conference Paper] [eCite] [Details]
1995	Woods GM, Grzegorczck AD, Field CM, Ragg SJ, Muller HK, 'Analysis of dendritic cells during carcinogen induced immunosuppression', 9th International Congress of Immunology, San Francisco, USA, pp. 410. (1995) [Conference Extract] [eCite] [Details] Co-authors: Muller HK

Contract Report, Consultant's Report

(1 outputs)

Year	Citation	Altmetrics
2020	Zosky GR, Norris K, Woods G, Flies A, 'RTA in a COVID-19 Environment', Australian Antarctic Division (AAD), Tasmania, Australia (2020) [Contract Report] [eCite] [Details] Co-authors: Zosky GR; Norris K; Flies A

Year

Citation

Altmetrics

2020

Zosky GR, Norris K, Woods G, Flies A, 'RTA in a COVID-19 Environment', Australian Antarctic Division (AAD), Tasmania, Australia (2020) [Contract Report]

[eCite] [Details]

Co-authors: Zosky GR; Norris K; Flies A

Other Public Output

(5 outputs)

Year	Citation	Altmetrics
2020	Flies AS, Patchett AL, Lyons B, Woods G, 'We developed tools to study cancer in Tasmanian devils. They could help fight disease in humans', The Conversation, online, 2 July 2020 (2020) [Magazine Article] [eCite] [Details] Co-authors: Flies AS; Patchett AL; Lyons B Tweet
2016	Flies AS, Woods GM, 'Deadly disease can 'hide' from a Tasmanian devil's immune system', The Conversation (2016) [Magazine Article] [eCite] [Details] Co-authors: Flies AS Tweet
2014	Pinfold T, Woods GM, Bettiol SS, Brown GK, 'The Devil's Details', The Scientist, online, 1 November, 2014 (2014) [Magazine Article] [eCite] [Details] Co-authors: Pinfold T; Bettiol SS; Brown GK
1999	Woods GM, 'Uni work may help beat diseases', Mercury, Hobart, Tasmania, 6 September 1999 (1999) [Newspaper Article] [eCite] [Details]
1999	Woods GM, 'Cash injection aids research', Australian, Melbourne, Victoria, 15/12/99 (1999) [Newspaper Article] [eCite] [Details]

Grants & Funding

The high quality and valuable contribution of Prof Wood's research continues to be recognised through ongoing support. In recent years his pivotal role in the Tasmanian Devil Facial Tumour Disease (DFTD) research programme has attracted funding from both the ARC and a number of smaller funding bodies.

Funding Summary

Number of grants

127

Total funding

$7,373,881

Projects

Advice to the AAD (PMU) re RTA in a COVID19 Environment (2020)$10,000

Description: Literature review and recommendations to the Australian Antarctic Division regarding the Return to Australia for current Antarctic Expeditioners in a COVID19 environment.
Funding: Australian Antarctic Division ($10,000)
Scheme: Consultancy
Administered By: University of Tasmania
Research Team: Zosky GR; Flies AS; Woods GM; Norris K
Year: 2020

Identification of devil facial tumour-associated antigens for vaccine development (2018 - 2019)$34,256

Description: The current DFTD vaccine can induce anti-DFTD immune responses, but the scalability and efficacy of the vaccine needs to be improved to deliver a broad conservation impact. This proposal builds on ongoing vaccine research to identify tumour-associated antigens that can be used to produce a highly replicable and scalable DFTD vaccine.
Funding: University of Tasmania Foundation Inc ($34,256)
Scheme: Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By: University of Tasmania
Research Team: Flies AS; Woods GM; Lyons AB; Wilson RR
Period: 2018 - 2019

Good cells battling bad cells: Cell-mediated immunity and transmissible cancer in the Tasmanian devil (2018 - 2020)$17,609

Description: This project is focused in investigating the cell-mediated immunity in wild devils and its relation to DFTD, contributing complementary and relevant information to the current efforts to the vaccine development against DFTD.
Funding: Holsworth Wildlife Research Endowment ($17,609)
Scheme: Grant
Administered By: University of Tasmania
Research Team: Lyons AB; Woods GM; Espejo CI
Period: 2018 - 2020

Advanced high resolution biomolecular analysis facility for Tasmania (2018)$350,790

Description: This proposal seeks support for an advanced, multi-purpose mass spectrometry platform for high-throughput and targeted biomolecular analysis, including proteomics and metabolomics. The intended purpose of the proposed infrastructure is to provide a centralised state-of-the-art facility that supports internationally competitive research programs in plant science, agricultural research, food safety, animal and human health research and separation science at the University of Tasmania (UTAS) and within the broader Tasmanian scientific community. Theanticipated benefit is a greatly enhanced capacity for leading edge research of national significance that alignswith the UTAS strategic research plan and national priorities.
Funding: Australian Research Council ($350,790)
Scheme: Grant-Linkage Infrastructure
Administered By: University of Tasmania
Research Team: Smith SM; Paull B; Woods GM; King AE; Wilson RR
Year: 2018
Grant Reference: LE180100059

Immunisation to protect against transmissible cancers in Tasmanian devils (2018 - 2020)$303,931

Funding: Australian Research Council ($303,931)
Scheme: Grant-Discovery Projects
Administered By: University of Tasmania
Research Team: Woods GM; Lyons AB; Corcoran L; Hayball J; Murphy J; Flies AS
Period: 2018 - 2020
Grant Reference: DP180100520

A live-attenuated vaccine (DFT-Off) to promote long-term anti-DFTD immunity (2017 - 2018)$35,000

Description: We have developed a system that allows us to switch genes on/off in devil facial tumour (DFT) cells. The DFT-Off cells have the potential to be used as a live-attenuated vaccine, which generally perform better than killed vaccines, that provides long-term protection against both forms of DFT disease (DFTD).
Funding: University of Tasmania Foundation Inc ($35,000)
Scheme: Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By: University of Tasmania
Research Team: Flies AS; Woods GM; Lyons AB
Period: 2017 - 2018

Distribution, prevalence and epidemiology of DFTD and DFT2 on the d Entrecasteaux channel area (2017)$31,130

Description: Two different transmissible cancers (DFTD and DFT2) are present in south-eastern Tasmania. This study will assess the distribution, prevalence, infection dynamics and survival after infection in both cancers. This information will create a baseline dataset for evaluating the threat of DFT2 and its possible interactions and selective processes with DFTD.
Funding: University of Tasmania Foundation Inc ($31,130)
Scheme: Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By: University of Tasmania
Research Team: Hamede Ross RK; Jones ME; Woods GM; Darby JM
Year: 2017

CRISPR screen to identify key genes driving DFTD (2017)$33,500

Description: We will apply leading genomic techniques to identify the genes essential for the proliferation of the Tasmanian Devil Facial Tumour. By systematically disrupting each gene in the cancer, we will also identify genes which help the tumour evade the immune system.
Funding: University of Tasmania Foundation Inc ($33,500)
Scheme: Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By: University of Tasmania
Research Team: Hewitt A; Liu G; Woods GM; Flies AS; Cook AL
Year: 2017

Evaluating the benefits in Tasmanian devils of immune responses to transmissible cancer (2017)$25,000

Description: A one year field and laboratory study to further our work on the evolution of resistance and tolerance in Tasmanian devils to facial tumor disease and to advance knowledge of immunology of devils for vaccine research. This work is a collaboration between the School of Biological Sciences and the Menzies Institute for Medical Research.
Funding: University of Tasmania Foundation Inc ($25,000)
Scheme: Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By: University of Tasmania
Research Team: Jones ME; Hamede Ross RK; Carver SS; Woods GM
Year: 2017

Developing DFTD vaccination approaches to favour cell mediated anti-tumour immunity (2017 - 2018)$32,304

Description: To successfully vaccinate Tasmanian devils against DFTD, a particular form of response known as cell mediated immunity is needed. This project will test the ability of two distinct approaches to enhance cell mediated immune responses against DFTD.
Funding: University of Tasmania Foundation Inc ($32,304)
Scheme: Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By: University of Tasmania
Research Team: Lyons AB; Patchett AL; Woods GM
Period: 2017 - 2018

Proteomics for Tasmanian devils: a DFTD pre-clinical test (2017)$15,000

Description: Proteins within the circulatory system offer insight into the pathophysiology of an individual, and protein biomarkers are frequently the basis for clinical diagnostic tests. This project will use proteomics to compare serum from non-infected and DFTD-infected Tasmanian devils to identify a DFTD-specific protein signature that could be used to develop a diagnostic test for early detection of DFTD.
Funding: University of Tasmania Foundation Inc ($15,000)
Scheme: Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By: University of Tasmania
Research Team: Wilson RR; Hamede Ross RK; Woods GM
Year: 2017

Evaluation of the role natural killer (NK) cells in protection against DFTD (2017)$26,487

Description: Natural Killer (NK) cells have a major role in the first line of defence against cancer. This project will investigate the presence and function of NK cells in the Tasmanian devil. The ultimate goal is to determine if NK cells are involved in the rejection of DFTD tumours.
Funding: University of Tasmania Foundation Inc ($26,487)
Scheme: Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By: University of Tasmania
Research Team: Woods GM; Lyons AB; Flies AS
Year: 2017

Deciphering the cellular origin of the second Devil Facial Tumour Disease (DFT2) (2017)$34,165

Description: We have established a multifaceted study to understand the cellular origin of DFT2 by producing large datasets with gene and protein profiles for DFT1 and DFT2. This proposal will use bioinformatics tools for the analysis of these data and the interpretation of the results in order to promote a more comprehensive understanding of the biology of DFTD
Funding: University of Tasmania Foundation Inc ($34,165)
Scheme: Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By: University of Tasmania
Research Team: Woods GM; Tovar Lopez CD; Wilson RA; McKay M; Papenfuss A
Year: 2017

Tasmanian Devil Vaccine research (2016 - 2019)$537,451

Description: To develop a vaccine against Devil Facial Tumour Disease
Funding: University of Tasmania Foundation Inc ($537,451)
Scheme: Donation - Individual
Administered By: University of Tasmania
Research Team: Woods GM; Lyons AB
Period: 2016 - 2019

Translating human cancer immunotherapy techniques for use in pets and Tasmanian devils (2016 - 2017)$140,000

Description: Immunotherapeutics targeting PD-1 and CTLA4 have shown unprecedented success in treating human cancers. Surprisingly, little is known to date on the potential for translating these human immunotherapy approaches into cancer treatments for veterinary medicine. The Tasmanian devil facial tumours (DFTs) and canine transmissible venereal tumour (CTVT) provide unique opportunities to assess immunotherapeutic treatment regimens for two naturally occurring tumours. Our ongoing work on the DFT has already developed ten anti-PD-1, nine anti-PD-L1 (aka B7-H1), and four anti-CTLA4 monoclonal antibodies (mAbs) that are highly specific for devil proteins. We have developed a system that can be used to rapidly generate new mAbs against additional target proteins. Importantly, this system can be readily applied to the production of antibodies that target proteins in other species. We have already begun cloning target genes in dogs, and will begin production of recombinant dog proteins, cell lines, and mAbs in 2016. The devil immunology group will develop dog-specific mAbs, and perform in vitro testing functional testing of the mAbs. The first batch of antibodies for PETization will be delivered to Nexvet in January, 2017. The initial functional testing of the antibodies performed by the devil immunology team will generate vital preliminary data to support planned ARC Linkage Project application in 2016-2017 in order to leverage funds for ongoing collaborative research. Establishing a solid connection between Nexvet and the devil immunology team prior to submission of the ARC Linkage Project application will greatly increase the probability receiving a Linkage Project award and leveraging funds. This research could help save an iconic Australian animal from extinction, develop immunotherapeutics to improve and extend the lives of pets around the world, and help to drive an emerging market for pharmaceuticals for pets.
Funding: Department of Industry, Science, Energy and Resources ($50,000); Nexvet Australia Pty Ltd ($90,000)
Scheme: Contract Research
Administered By: University of Tasmania
Research Team: Flies AS; Woods GM; Lyons AB; Hayball J
Period: 2016 - 2017

Improving the DFTD vaccine by targeting key immune signalling molecules (2016)$35,000

Description: We have discovered that our current vaccine approach of using interferon-gamma (IFNg) to make the DFTD tumour cells visible to the devil immune system also induces upregulation of molecules that inhibit anti-tumour immune responses. We are now modifying the vaccine to counteract the effects of the inhibitory molecules.
Funding: University of Tasmania Foundation Inc ($35,000)
Scheme: Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By: University of Tasmania
Research Team: Flies AS; Woods GM; Lyons AB
Year: 2016

Detection of activated Tasmanian devil cytotoxic lymphocytes by a rapid RNA detection assay (2016)$34,999

Description: Monitoring the immune response of vaccinated Tasmanian devils requires analysis of cell mediated immunity .The current assays we use demonstrate killing of DFTD cells but fail to reveal cytotoxic cell activation and themeans of cell death. We plan incorporate a new assay that employs fluorescent in situ hybridisation andbranched DNA amplification technique for simultaneous measurement of RNA transcripts in single cells usingflow cytometry. The advantages of the proposed assay is that it provides a rapid and biologically relevantanalysis of fresh blood samples taken from Tasmanian devils and measures the activity level of these cellsequivalent to when they were in circulation. This will determine if cytotoxic cells are activated to induce targetcell death. We will be able to analyse key gene expression markers for activation such as IFN-gamma andLAMP-I.
Funding: University of Tasmania Foundation Inc ($34,999)
Scheme: Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By: University of Tasmania
Research Team: Pinfold T; Bettiol SS; Woods GM; Lyons AB
Year: 2016

Immunological approach to protect Tasmanian devils against devil facial tumour disease (2015 - 2021)$139,262

Description: This project is aimed at refining our immunisation procedure that stimulates the devil's immune system to recognise and kill DFTD tumour cells.
Funding: University of Tasmania Foundation Inc ($139,262)
Scheme: Grant - Institutional
Administered By: University of Tasmania
Research Team: Lyons AB; Kreiss A; Woods GM; Pye RJ; Flies A
Period: 2015 - 2021

Vaccination of Tasmanian devils to induce a memory response against DFTD (2015)$29,000

Description: This project will test whether a newly developed vaccination strategy will protect the Tasmanian devil from acquiring the deadly Devil Facial Tumour Disease (DFTD). The vaccination consists of a series of booster immunisations, similar to the chicken pox vaccine, that aims to prime the devil's memory immune response to recognise and eradicate invading tumour cells. The project will provide valuable knowledge as to whether the vaccine and long-term booster injection will protect devils from DFTD. Results will be communicated with the scientific and public community by scientific presentations, conference presentations, community presentations and media releases.
Funding: University of Tasmania Foundation Inc ($29,000)
Scheme: Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By: University of Tasmania
Research Team: Kreiss A; Woods GM; Pye RJ
Year: 2015

Up-regulating MHC expression of DFTD cells in vivo by treating established tumours with imiquimod (2015)$28,000

Description: DFTD cells avoid immune recognition and destruction because they turn off important genes. Recent research discovered that imiquimod, a drug used to treat skin cancer, can turn on these genes. This project will determine if imiquimod makes DFTD cells visible to the Tasmanian devil's immune system, thereby inducing an immune response.
Funding: University of Tasmania Foundation Inc ($28,000)
Scheme: Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By: University of Tasmania
Research Team: Pinfold T; Bettiol SS; Woods GM
Year: 2015

Can DFTD cells be made visible to the Tasmanian devil immune system? (2014)$28,000

Description: DFTD should be recognised and rejected by the Tasmanian devil's immune system as a foreign graft, but it appears to be invisible. This project aims to discover if re-expression of MHC molecules allows DFTD cells to be recognised as an allograft and ultimately be killed by the devil immune system. In vitro cell culture techniques and flow cytometry will be used to examine responses. The demonstration that tumour cells can be recognized by cytotoxic T cells will aid the design of immune based strategies for prevention and therapy.
Funding: University of Tasmania Foundation Inc ($28,000)
Scheme: Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By: University of Tasmania
Research Team: Lyons AB; Woods GM
Year: 2014

The immune system of the Tasmanian Devil and how it is affected by Devil Facial Tumour Disease (DFTD) (2014 - 2016)$21,600

Description: The aims of this project are: to determine the ratio of T lymphocyte subsets (CD4 and CD8) in healthy devils and if this is altered in diseased devils; to assess the serum concentrations of immunoglobulins (IgG and IgM) in healthy devils and if this is altered in diseased devils; to survey serum samples from healthy and diseased devils to identify antibodies to DFTD, which will serve as a biomarker for natural immunity to DFTD.
Funding: Holsworth Wildlife Research Endowment ($21,600)
Scheme: Grant
Administered By: University of Tasmania
Research Team: Woods GM; Pye RJ
Period: 2014 - 2016

Co-signalling immunotherapy to treat DFTD (2014)$20,000

Description: Immunotherapies targeting immune signalling molecules have recently yielded unprecedented results in treating human cancer. The genes targeted in these ground-breaking trials have been identified in devils; this study will assess the potential for translating the already proven human therapies into treatment for the DFTD.
Funding: University of Tasmania Foundation Inc ($20,000)
Scheme: Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By: University of Tasmania
Research Team: Flies A; Woods GM
Year: 2014

Co-signalling immunotherapy to treat DFTD (2014 - 2016)$99,360

Description: Immunotherapies targeting immune signalling molecules have recently yielded unprecedented results in treating human cancer. The genes targeted in these ground-breaking trials have been identified in devils. This study will assess the potential for translating the already proven human therapies into a treatment for the DFTD. This research aims to determine if DFTD cells can be modified to induce cytotoxic lymphocyte activity which has the potential to be used as therapy to treat devil facial tumour disease.
Funding: Morris Animal Foundation ($99,360)
Scheme: Fellowship
Administered By: University of Tasmania
Research Team: Woods GM; Flies A
Period: 2014 - 2016

Development of methods for therapeutic vaccines against Devil facial tumour disease (2013)$34,971

Funding: University of Tasmania Foundation Inc ($34,971)
Scheme: Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By: University of Tasmania
Research Team: Brown GK; Woods GM
Year: 2013

Host-tumour Interplay in Tasmanian Devils with Devil Facial Tumour Disease: Can Immune Cells be Harnessed for Therapy? (2013 - 2015)$380,000

Description: Tasmanian devils only exist in Tasmania and Devil Facial Tumour Disease, an infectious cancer, could cause the extinction of the Tasmanian devil. This project will determine if Devil Facial Tumour Disease reduces the effectiveness of the devil's immune system and test if activated immune cells can protect against this disease.
Funding: Australian Research Council ($380,000)
Scheme: Grant-Discovery Projects
Administered By: University of Tasmania
Research Team: Woods GM; Lyons AB; Corcoran L
Period: 2013 - 2015
Grant Reference: DP130100715

Vaccination as a potential strategy to protect Tasmanian devil against extinction in the wild due to a transmissible cancer (2013)$54,800

Funding: Mazda Foundation ($54,800)
Scheme: Grant
Administered By: University of Tasmania
Research Team: Woods GM
Year: 2013

Development of an immune enhancing vaccine to protect Tasmanian devils against a contagious cancer (2013 - 2015)$412,912

Description: The iconic Tasmanian devil is threatened with extinction from a uniformly fatal transmissible facial cancer. This project builds on existing research on the cancer cells that can be recognised by the devil immune system. It will develop and test a vaccine against the tumour, which will ultimately protect devils in the wild.
Funding: Australian Research Council ($412,912)
Scheme: Grant-Linkage Projects Round 1
Administered By: University of Tasmania
Research Team: Woods GM; Lyons AB
Period: 2013 - 2015
Grant Reference: LP130100218

Activation of innate immune cells to promote a protective immune response against devil facial tumour cells in murine model of DFTD (2013)$35,000

Description: This project will determine if stimulants of the innate immune system can protect against DFTD. Consequently it will assist in the development of a vaccine. Due to the limited availability of Tasmanian devils for vaccine research, the research will utilise a mouse model of DFTD.
Funding: University of Tasmania Foundation Inc ($35,000)
Scheme: Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By: University of Tasmania
Research Team: Woods GM; Bettiol SS; Pinfold T
Year: 2013

Maintenance of a post-insurance population of Tasmanian devils for research and welfare (2013)$31,031

Description: Vaccine related research requires access to healthy devils that can be immunised and analysed for immune responses. This project will contribute to keeping the Fern Tree devil research facility functional to maintain nine healthy devils for a 6-month period.
Funding: University of Tasmania Foundation Inc ($31,031)
Scheme: Grant-Tasmanian Devil Management Project Grant
Administered By: University of Tasmania
Research Team: Woods GM
Year: 2013

Novel strategies to protect Tasmanian devils against Tasmanian Devil Facial Tumour Disease (2012 - 2013)$30,000

Funding: Donation via University of Tasmania Foundation ($30,000)
Scheme: Donation - Individual
Administered By: University of Tasmania
Research Team: Woods GM; Kreiss A
Period: 2012 - 2013

MHC-I expression on DFTD tumour cells and monoclonal antibodies as a strategy to induce and analyse an immune response to DFTD (2012)$29,736

Funding: University of Tasmania Foundation Inc ($29,736)
Scheme: Award-Eric Guiler Foundation
Administered By: University of Tasmania
Research Team: Kreiss A; Woods GM; Lyons AB; Tovar Lopez CD
Year: 2012

New vaccination strategy to protect Tasmanian Devils against the devil facial tumour disease (2012 - 2013)$35,000

Funding: University of Tasmania Foundation Inc ($35,000)
Scheme: Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By: University of Tasmania
Research Team: Kreiss A; Woods GM
Period: 2012 - 2013

Selection of devil facial tumour associated antigens as a tool for the development of a prophylactic vaccine (2012)$33,661

Funding: University of Tasmania Foundation Inc ($33,661)
Scheme: Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By: University of Tasmania
Research Team: Tovar Lopez CD; Woods GM
Year: 2012

Cytotoxic devil lymphocytes as a therapy against Devil Facial Tumour Disease (2012)$9,900

Funding: The Select Foundation ($9,900)
Scheme: Grant-Small Grants Scheme
Administered By: University of Tasmania
Research Team: Woods GM; Pinfold T; Brown GK
Year: 2012

Gene therapy in Human Cells Mediated by Integrase from a Yeast Retrotransposon (2011)$6,500

Funding: David Collins Leukaemia Foundation ($6,500)
Scheme: Grant
Administered By: University of Tasmania
Research Team: Woods GM; Casey NP
Year: 2011

Upgrade of the flow cytometry facility of the Menzies Research Institute with a multi-parameter analytical flow cytometer CyAn ADP 9 Color for key applications (2011)$75,000

Funding: Clive & Vera Ramaciotti Foundation ($75,000)
Scheme: Grant-Equipment
Administered By: University of Tasmania
Research Team: Korner H; McMorran BJ; Woods GM; Holloway AF; West AK
Year: 2011

Characterisation of DFTD tumour proteins eliciting immune responses in Tasmanian devils (2011)$26,500

Funding: University of Tasmania Foundation Inc ($26,500)
Scheme: Donation-Dr Eric Guiler Tasmanian Devil Research
Administered By: University of Tasmania
Research Team: Tovar Lopez CD; Woods GM; Kreiss A
Year: 2011

Evaluation of the ability of vitamin D and metallothionein to protect against UV-radiation induced skin cancer (2011)$70,000

Funding: Cancer Council of Tasmania ($70,000)
Scheme: Grant-Cancer Research
Administered By: University of Tasmania
Research Team: Woods GM; West AK; McGee HM; Muller HK
Year: 2011

Production of monoclonal antibodies to identify important immune cell populations of the Tasmanian Devil (2011)$29,600

Funding: University of Tasmania Foundation Inc ($29,600)
Scheme: Donation-Dr Eric Guiler Tasmanian Devil Research
Administered By: University of Tasmania
Research Team: Woods GM; Corcoran L; Belov K
Year: 2011

Infrastructure Grant - Expansion of captivity facility in Fern Tree (2010)$13,800

Funding: University of Tasmania Foundation Inc ($13,800)
Scheme: Donation-Dr Eric Guiler Tasmanian Devil Research
Administered By: University of Tasmania
Research Team: Kreiss A; Woods GM
Year: 2010

Use of a murine model to investigate devil facial tumour disease (2010)$24,000

Funding: University of Tasmania Foundation Inc ($24,000)
Scheme: Donation-Dr Eric Guiler Tasmanian Devil Research
Administered By: University of Tasmania
Research Team: Kreiss A; Woods GM
Year: 2010

Assessing the role of metallothionein in the development of non-melanoma skin cancer (2010)$5,000

Funding: Royal Hobart Hospital Research Foundation ($5,000)
Scheme: Grant-Starter
Administered By: University of Tasmania
Research Team: McGee HM; West AK; Woods GM; Bennett WR
Year: 2010

Role of vitamin D3 and metallothionein in protection against melanoma (2010)$86,250

Funding: Cancer Council of Tasmania ($86,250)
Scheme: Grant-Cancer Research
Administered By: University of Tasmania
Research Team: Woods GM; Chung RS; Walker G; Muller HK
Year: 2010

Greg Woods - Discretionary Account (2009)$10,000

Funding: Menzies Institute for Medical Research ($10,000)
Scheme: Consultancy
Administered By: University of Tasmania
Research Team: Woods GM
Year: 2009

Investigating the role of metallothionein in ultraviolet radiation-induced skin cancer (2009)$9,200

Funding: Cancer Council of Tasmania ($9,200)
Scheme: Grant-Small
Administered By: University of Tasmania
Research Team: McGee HM; Pankhurst MW; Chung RS; Woods GM
Year: 2009

The involvement of tumour cytokine production in the pathogenesis of Tasmanian Devil (Sarcophilus Harrisii) Facial Tumour Disease (DFTD) (2009)$17,700

Funding: University of Tasmania Foundation Inc ($17,700)
Scheme: Donation-Dr Eric Guiler Tasmanian Devil Research
Administered By: University of Tasmania
Research Team: McGee HM; Kreiss A; Woods GM
Year: 2009

Influence of vitamin D and gender on UVB-induced DNA damage, immunoregulation and development of melanoma (2009)$54,400

Funding: Cancer Council of Tasmania ($54,400)
Scheme: Grant-Cancer Research
Administered By: University of Tasmania
Research Team: Woods GM; Muller HK
Year: 2009

An Immunological and Immunogenetic Approach to Understand and to Protect Tasmanian Devils against Devil Facial Tumour Disease (2009 - 2011)$490,000

Funding: Australian Research Council ($400,000)
Scheme: Grant-Linkage Projects Round 1
Administered By: University of Tasmania
Research Team: Woods GM; Belov K; Kreiss A
Period: 2009 - 2011
Grant Reference: LP0989727

Save the Tasmanian Devil - identification of genetically resistant devils (2009)$65,694

Funding: Turner Foundation Inc ($65,694)
Scheme: Grant-Endangered Species Program
Administered By: University of Tasmania
Research Team: Woods GM
Year: 2009

Establishment of a mouse model to study the biology of Devil Facial Tumour Disease (DFTD) (2009)$20,255

Funding: University of Tasmania Foundation Inc ($20,255)
Scheme: Donation-Dr Eric Guiler Tasmanian Devil Research
Administered By: University of Tasmania
Research Team: Woods GM; Kreiss A; Tovar Lopez CD; Shellie RA; Hilder EF; Breadmore MC
Year: 2009

Flow cytometer and ancillary assay kits (2008)$150,000

Funding: Royal Hobart Hospital Research Foundation ($150,000)
Scheme: Grant-Equipment
Administered By: University of Tasmania
Research Team: Walters EH; Woods GM
Year: 2008

Establishment of a Confocal/multiphoton Microscope for Imaging of Living Systems (2008)$300,000

Funding: Australian Research Council ($300,000)
Scheme: Grant-Linkage Infrastructure
Administered By: University of Tasmania
Research Team: Vickers JC; Foote SJ; Small DH; Walters EH; Hallegraeff GM; West AK; Chung RS; Woods GM; Dickson TC; Nowak BF; Bolch CJS
Year: 2008
Grant Reference: LE0882701

The effect of UV radiation and vitamin D deficiency on the development of the skin immune system (2008)$50,000

Funding: Cancer Council of Tasmania ($50,000)
Scheme: Grant-Cancer Research
Administered By: University of Tasmania
Research Team: Woods GM; Muller HK
Year: 2008

Silencing the AML1/ETO fusion gene as a treatment strategy for acute myeloid leukaemia (2008)$7,704

Funding: Clifford Craig Foundation ($7,704)
Scheme: Grant
Administered By: University of Tasmania
Research Team: Woods GM; Holloway AF; Casey NP
Year: 2008

Professional Development Application - N Casey (2008)$400

Funding: David Collins Leukaemia Foundation ($400)
Scheme: Award-Professional Development
Administered By: University of Tasmania
Research Team: Woods GM; Casey NP
Year: 2008

Immunohistochemistry as a tool to search for evidence of immunity against Devil Facial Tumour Disease (DFTD) (2008)$16,657

Funding: University of Tasmania Foundation Inc ($16,657)
Scheme: Donation-Dr Eric Guiler Tasmanian Devil Research
Administered By: University of Tasmania
Research Team: Woods GM; Kreiss A
Year: 2008

Analysis of Devil Tumour Disease to identify unique tumour antigens for diagnosis and vaccination (2008)$16,251

Funding: University of Tasmania Foundation Inc ($16,251)
Scheme: Donation-Dr Eric Guiler Tasmanian Devil Research
Administered By: University of Tasmania
Research Team: Woods GM; Kreiss A; Tovar Lopez CD
Year: 2008

Platypus Partnership - A Community and Science-based Conservation Programme (2007 - 2008)$50,000

Funding: Natural Heritage Trust ($50,000)
Scheme: Grant-Natural Resource Management, Northern Region
Administered By: University of Tasmania
Research Team: Geraghty DP; Stewart NJ; Woods GM; Tristram SG; Forteath GN
Period: 2007 - 2008

Effects of UV radiation and vitamin D deficiency on the development of the skin immune system (2007)$35,000

Funding: Cancer Council of Tasmania ($35,000)
Scheme: Grant-Cancer Research
Administered By: University of Tasmania
Research Team: Woods GM; Muller HK
Year: 2007

Investigation of the potential of lentivirus-delivered shRNA in inhibiting the proliferation of human leukemic cells in vivo (2007)$10,514

Funding: David Collins Leukaemia Foundation ($10,514)
Scheme: Grant
Administered By: University of Tasmania
Research Team: Woods GM; Casey NP
Year: 2007

An immunological and immunogenetic approach to protect Tasmanian devils against Devil Facial Tumour Disease (DFTD) (2007)$23,524

Funding: University of Tasmania Foundation Inc ($23,524)
Scheme: Donation-Dr Eric Guiler Tasmanian Devil Research
Administered By: University of Tasmania
Research Team: Woods GM; Kreiss A
Year: 2007

Tasmanian Devil Research Scholarship - A Kreiss (2007)$19,321

Funding: Qantas Airways Ltd ($19,321)
Scheme: Scholarship-Tasmanian Devil Research
Administered By: University of Tasmania
Research Team: Woods GM; Kreiss A
Year: 2007

Evaluation of Abalone Haemocyanin and Blood Extracts on the Immune Response and other related health parameters (2006 - 2007)$160,826

Funding: Associate Professor Greg Woods ($160,826)
Scheme: Contract Research
Administered By: University of Tasmania
Research Team: Woods GM; Bettiol SS; Carroll V
Period: 2006 - 2007

Tasmanian Wildlife Research Advisory Committee Devil Facial Tumour grant (2006 - 2008)$63,132

Funding: Donation via University of Tasmania Foundation ($63,132)
Scheme: Donation - Individual
Administered By: University of Tasmania
Research Team: Woods GM
Period: 2006 - 2008

Mucor Amphibiorum Infection of Platypus (Ornithorhynchus anatinus) in Tasmania - What is the Threat to Platypus and Other Wildlife? (2006)$10,000

Funding: Norske-Skog (Australasia) Pty Ltd ($10,000)
Scheme: Agreement
Administered By: University of Tasmania
Research Team: Geraghty DP; Stewart NJ; Woods GM; Forteath GN; Langstaff I; Connolly J
Year: 2006

Microscopic, Biochemical and Functional Characterisation of NK Cell Invasion into Tumour Cells (2006)$51,600

Funding: Cancer Council of Tasmania ($51,600)
Scheme: Grant-Cancer Research
Administered By: University of Tasmania
Research Team: Trambas CM; Woods GM
Year: 2006

Long Term Effects of UV-B Irradiation on the Developing Skin Immune System (2006)$37,750

Funding: Cancer Council of Tasmania ($37,750)
Scheme: Grant-Cancer Research
Administered By: University of Tasmania
Research Team: Woods GM; Muller HK
Year: 2006

Analysis of a Lentivirus-delivered shRNA to Prevent Leukaemic Cell Growth (2006)$10,000

Funding: David Collins Leukaemia Foundation ($10,000)
Scheme: Grant
Administered By: University of Tasmania
Research Team: Woods GM; Casey NP
Year: 2006

Paul Mackay Bolton Scholarship for Cancer Research (2006)$18,750

Funding: Royal Australasian College of Surgeons ($18,750)
Scheme: Scholarship
Administered By: University of Tasmania
Research Team: Woods GM; Castley AJ
Year: 2006

Marinova Consultancy (2005 - 2006)$21,000

Funding: Marinova Pty Ltd ($21,000)
Scheme: Consultancy
Administered By: University of Tasmania
Research Team: Woods GM
Period: 2005 - 2006

The Skin Immune System in Cutaneous Carcinogenesis (2005 - 2007)$74,895

Funding: National Health & Medical Research Council ($74,895)
Scheme: Scholarship-Postgraduate:Medical
Administered By: University of Tasmania
Research Team: Woods GM; Malley RC
Period: 2005 - 2007
Grant Reference: 352624

Microscopic, Biochemical and Functional Characterisation of Natural Killer Cell Invasion into Tumour Target Cells - Emperipolesis (2005)$40,000

Funding: Cancer Council of Tasmania ($40,000)
Scheme: Grant-Cancer Research
Administered By: University of Tasmania
Research Team: Trambas CM; Woods GM
Year: 2005

Long Term Effects of UVB Irradiation on Neonatal Langerhans Cells (2005)$35,000

Funding: Cancer Council of Tasmania ($35,000)
Scheme: Grant-Cancer Research
Administered By: University of Tasmania
Research Team: Woods GM; Muller HK
Year: 2005

Vitamin D in the Skin Immune System (2005)$14,980

Funding: Arthritis Australia ($14,980)
Scheme: Grant-Sir Warwick Fairfax Memorial
Administered By: University of Tasmania
Research Team: Woods GM; Muller HK
Year: 2005

Development of the Skin Immune System and the Effect of Exposure to Sunlight (2005)$12,855

Funding: Royal Hobart Hospital Research Foundation ($12,855)
Scheme: Grant-Research
Administered By: University of Tasmania
Research Team: Woods GM; Muller HK
Year: 2005

Vitamin D Deficiency in Skin Cancer Development (2005)$12,000

Funding: Royal Hobart Hospital Research Foundation ($12,000)
Scheme: Grant-Research
Administered By: University of Tasmania
Research Team: Woods GM; Muller HK; Malley RC
Year: 2005

Spectramax M2 Multimode ELISA Plate Reader with Softmax Pro Software (2005)$33,019

Funding: National Health & Medical Research Council ($33,019)
Scheme: Grant-Equipment
Administered By: University of Tasmania
Research Team: Walters EH; Reid DW; Woods GM; Dickson TC
Year: 2005
Grant Reference: 264668

Langerhans Cells: From Birth to Maturity (2005)$4,800

Funding: Royal Hobart Hospital Research Foundation ($4,800)
Scheme: Grant-Starter
Administered By: University of Tasmania
Research Team: Woods GM; Castley AJ
Year: 2005

Skin Cancer and non-Hodgkin's Lymphoma: What is the Risk of Developing both Primary Cancers in Tasmania? (2004)$10,000

Funding: Cancer Council of Tasmania ($10,000)
Scheme: Grant-Cancer Research
Administered By: University of Tasmania
Research Team: Venn A; Blizzard CL; Dwyer T; Woods GM
Year: 2004

A Pilot Study to Examine Biological, Lifestyle and Genetic Risk Factors Associated with the Development of Multiple Non-melanoma Skin Cancers (2004)$22,000

Funding: University of Tasmania ($22,000)
Scheme: Grant-Institutional Research Scheme
Administered By: University of Tasmania
Research Team: Venn A; Dwyer T; Blizzard CL; Woods GM; Muller HK; Dickinson JL
Year: 2004

Immunosuppression by Carcinogen Induced Immature Dendritic Cells: Gene Activation and Intervention Strategies (2004)$30,000

Funding: Cancer Council of Tasmania ($30,000)
Scheme: Grant-Cancer Research
Administered By: University of Tasmania
Research Team: Woods GM; Muller HK
Year: 2004

A Proteomics Approach to the Identification of Novel Immune Suppressor Factors in Neonatal Skin (2004)$7,273

Funding: Royal Hobart Hospital Research Foundation ($7,273)
Scheme: Grant-Research
Administered By: University of Tasmania
Research Team: Woods GM; Lord RJ
Year: 2004

Shandon Cytopsin 4 Cytocentrifuge (2004)$13,898

Funding: National Health & Medical Research Council ($13,898)
Scheme: Grant-Equipment
Administered By: University of Tasmania
Research Team: Walters EH; Reid DW; Woods GM; Wood-Baker R
Year: 2004
Grant Reference: 264536

The Molecular Basis of Ceramide-Mediated Growth Arrest and Terminal Differentiation (2003)$40,000

Funding: Cancer Council of Tasmania ($40,000)
Scheme: Grant-Cancer Research
Administered By: University of Tasmania
Research Team: Ragg SJ; Woods GM; Lowenthal RM
Year: 2003

The Molecular Basis of Ceramide-Mediated Growth Arrest and Terminal Differentiation (2003)$33,300

Funding: David Collins Leukaemia Foundation ($33,300)
Scheme: Grant
Administered By: University of Tasmania
Research Team: Ragg SJ; Woods GM; Lowenthal RM
Year: 2003

A Pilot Study to Examine Biological, Lifestyle and Genetic Risk Factors Associated with the Development of Second and Subsequent Non-melanoma Skin Cancers in People with a History of Skin Cancer (2003)$18,000

Funding: Cancer Council of Tasmania ($18,000)
Scheme: Grant-Cancer Research
Administered By: University of Tasmania
Research Team: Venn A; Dwyer T; Blizzard CL; Woods GM; Muller HK; Dickinson JL
Year: 2003

Immunosuppression by Carcinogen Induced Immature Dendritic Cells: Signalling Molecules, Potential Pathways and Intervention Strategies (2003)$30,000

Funding: Cancer Council of Tasmania ($30,000)
Scheme: Grant-Cancer Research
Administered By: University of Tasmania
Research Team: Woods GM; Muller HK; Wang Z
Year: 2003

Molecular Identification and Characterisation of Mini P-glycoproteins (2002)$13,636

Funding: Royal Hobart Hospital Research Foundation ($13,636)
Scheme: Grant-Research
Administered By: University of Tasmania
Research Team: Trambas CM; Woods GM
Year: 2002

Molecular Identification and Characterisation of Mini P-glycoproteins (2002)$29,720

Funding: David Collins Leukaemia Foundation ($29,720)
Scheme: Grant
Administered By: University of Tasmania
Research Team: Trambas CM; Woods GM
Year: 2002

Immunosuppression by Carcinogen Induced Immature Dendritic Cells: Signalling Molecules, Potential Pathways and Intervention Strategies (2002)$40,000

Funding: Cancer Council of Tasmania ($40,000)
Scheme: Grant-Cancer Research
Administered By: University of Tasmania
Research Team: Woods GM; Wang Z; Muller HK
Year: 2002

Analysis of Reduced IFN-y and Increased IL-12 (p40) as a Mechanism Contributing to Carcinogen Induced Immunosuppression (2002)$10,910

Funding: Royal Hobart Hospital Research Foundation ($10,910)
Scheme: Grant-Research
Administered By: University of Tasmania
Research Team: Woods GM; Muller HK
Year: 2002

Characterising Carcinogen Induced Immunosuppression and Tumor Escape (2001)$31,530

Funding: Cancer Council of Tasmania ($31,530)
Scheme: Grant-Cancer Research
Administered By: University of Tasmania
Research Team: Woods GM; Doherty KV; Muller HK
Year: 2001

Analysis of Mini-P-Glycoprotein in Normal and Leukaemic Cells (2001)$18,833

Funding: David Collins Leukaemia Foundation ($18,833)
Scheme: Grant
Administered By: University of Tasmania
Research Team: Woods GM
Year: 2001

Denskometer/2D Database Analysis & IEF System (Proteomics) (2001)$8,000

Funding: National Health & Medical Research Council ($8,000)
Scheme: Grant-Equipment
Administered By: University of Tasmania
Research Team: Woods GM; Muller HK
Year: 2001

Antigen Handling Costimulatory Molecule Expression and Intracellular Signalling of IL-10 Induced Human Tolerogenic Dendritic Cells (2001)$11,400

Funding: Royal Hobart Hospital Research Foundation ($11,400)
Scheme: Grant-Research
Administered By: University of Tasmania
Research Team: Woods GM; Hassan G; Muller HK
Year: 2001

Characterisation and Molecular Cloning of a Novel P-glycoprotein Homologue (2000)$25,000

Funding: David Collins Leukaemia Foundation ($25,000)
Scheme: Grant
Administered By: University of Tasmania
Research Team: Woods GM
Year: 2000

Tolerogenic dendritic cells as a potential therapy for autoimmune disease (combined with 106924: Immature cells induce suppressive immune responses) (2000 - 2002)$339,688

Funding: National Health & Medical Research Council ($339,688)
Scheme: Grant-Project Three Year
Administered By: University of Tasmania
Research Team: Woods GM; Doherty KV; Muller HK; Toh BH
Period: 2000 - 2002
Grant Reference: 137

Characterization and Molecular Cloning of a Novel and Ubiquitous P-glycoprotein Homologue (2000)$26,800

Funding: Australian Research Council ($26,800)
Scheme: Grant-Small
Administered By: University of Tasmania
Research Team: Woods GM; West AK
Year: 2000

Carcinogen Induced Immunosuppression: A Critical Role for Immature Epidermal Langerhans Cells (1999)$29,000

Funding: Cancer Council of Tasmania ($29,000)
Scheme: Grant-Cancer Research
Administered By: University of Tasmania
Research Team: Doherty KV; Woods GM; Muller HK
Year: 1999

Induction of immuno-suppression by functionality immature Langerhans cells (1999)$3,500

Funding: Clifford Craig Foundation ($3,500)
Scheme: Grant-Collaborative
Administered By: University of Tasmania
Research Team: Doherty KV; Muller HK; Woods GM
Year: 1999

Funding for Small Equipment - Microradiance Laser Confocal Imaging System (1999)$50,000

Funding: Australian Cancer Research Foundation ($50,000)
Scheme: Grant-Tasmanian Small Equipment
Administered By: University of Tasmania
Research Team: Woods GM; Doherty KV; Vickers JC; Muller HK
Year: 1999

Identifying a Specific and Sensitive Probe for Assessing P-glycoprotein Function (1999)$18,000

Funding: Cancer Council of Tasmania ($18,000)
Scheme: Grant-Cancer Research
Administered By: University of Tasmania
Research Team: Woods GM; Trambas CM
Year: 1999

Tolerogenic dendritic cells as a potential therapy for autoimmune disease (1999)$3,345

Funding: Clifford Craig Foundation ($3,345)
Scheme: Grant-Collaborative
Administered By: University of Tasmania
Research Team: Woods GM; Muller HK; Toh BH
Year: 1999

Down-regulation of Autoimmunity Utilising Modified Dendritic Cells (1998)$5,500

Funding: Clifford Craig Foundation ($5,500)
Scheme: Grant-Collaborative
Administered By: University of Tasmania
Research Team: Muller HK; Toh BH; Woods GM
Year: 1998

Development of a Laser Confocal Microscope System (1998)$25,000

Funding: Clive & Vera Ramaciotti Foundation ($25,000)
Scheme: Grant-Establishment
Administered By: University of Tasmania
Research Team: Vickers JC; Woods GM
Year: 1998

Immunology of healthy and diseased platypus (Ornithorhynchus anatinus). (1997 - 1999)$36,000

Funding: Australian Research Council ($36,000)
Scheme: Grant-Small
Administered By: University of Tasmania
Research Team: Munday BL; Woods GM
Period: 1997 - 1999

Towards a Novel Differentiation Therapy of Leukemia Using Ceramide (1997 - 2001)$118,549

Funding: Cancer Council of Tasmania ($118,549)
Scheme: Grant-Cancer Research
Administered By: University of Tasmania
Research Team: Woods GM; Ragg SJ; Lowenthal RM
Period: 1997 - 2001

Towards a Novel Differentiation Therapy of Leukaemia using Ceramide (1997 - 2001)$144,633

Funding: David Collins Leukaemia Foundation ($144,633)
Scheme: Scholarship
Administered By: University of Tasmania
Research Team: Ragg SJ; Woods GM; Lowenthal RM
Period: 1997 - 2001

Analysis of antigen presenting cells and T cells during carcinogen induced immunosuppression. (1997 - 1999)$161,896

Funding: National Health & Medical Research Council ($161,896)
Scheme: Grant-MRC Project
Administered By: University of Tasmania
Research Team: Woods GM; Muller HK
Period: 1997 - 1999
Grant Reference: 971331

Superspeed Centrifuge. (1997)$20,000

Funding: National Health & Medical Research Council ($20,000)
Scheme: Grant-Equipment
Administered By: University of Tasmania
Research Team: Woods GM; Kirov SM; Lyons AB; Muller HK
Year: 1997
Grant Reference: 971378

Detrimental alterations of antigen presenting cells and T cells during carcinogenesis (1997 - 1998)$38,000

Funding: Cancer Council of Tasmania ($38,000)
Scheme: Grant-Cancer Research
Administered By: University of Tasmania
Research Team: Woods GM; Muller HK
Period: 1997 - 1998

Superspeed Refrigerated Centrifuge (1997)$14,507

Funding: Clive & Vera Ramaciotti Foundation ($14,507)
Scheme: Grant-Establishment
Administered By: University of Tasmania
Research Team: Woods GM; Kirov SM
Year: 1997

EPICS large laser elite flow cytometer (1996)$30,000

Funding: Clive & Vera Ramaciotti Foundation ($30,000)
Scheme: Grant-Establishment
Administered By: University of Tasmania
Research Team: Muller HK; Woods GM
Year: 1996

Elite workstation for Flow Cytometry (single user) (1996)$10,000

Funding: National Health & Medical Research Council ($10,000)
Scheme: Grant-Equipment
Administered By: University of Tasmania
Research Team: Woods GM; Dandie GW; Lyons AB; Muller HK
Year: 1996
Grant Reference: 961451

Involvement of P-glycoprotein in the resistance to cancer chemotherapy and cytotoxicity (1996 - 1998)$31,600

Funding: David Collins Leukaemia Foundation ($31,600)
Scheme: Grant
Administered By: University of Tasmania
Research Team: Woods GM
Period: 1996 - 1998

Cutaneous tolerance induction. Down-regulation of autoimmunity (1995 - 1997)$186,141

Funding: National Health & Medical Research Council ($186,141)
Scheme: Grant-MRC Project
Administered By: University of Tasmania
Research Team: Muller HK; Toh BH; Woods GM
Period: 1995 - 1997
Grant Reference: 951249

Biohazard Cabinet (1995)$14,000

Funding: National Health & Medical Research Council ($14,000)
Scheme: Grant-Equipment
Administered By: University of Tasmania
Research Team: Muller HK; Kirov SM; Woods GM; Vickers JC
Year: 1995
Grant Reference: 951382

Analysis of Langerhans cell function during chemically and physically induced carcinogenesis (1995)$15,000

Funding: Cancer Council of Tasmania ($15,000)
Scheme: Grant
Administered By: University of Tasmania
Research Team: Woods GM; Muller HK
Year: 1995

Multidrug resistance and natural killer cells (1995)$10,000

Funding: David Collins Leukaemia Foundation ($10,000)
Scheme: Grant
Administered By: University of Tasmania
Research Team: Woods GM
Year: 1995

Analysis of Langerhans cell function during chemically and physically induced carcinogenesis (1994)$16,619

Funding: Tasmanian Cancer Council & W P Holman Clinics ($16,619)
Scheme: Grant
Administered By: University of Tasmania
Research Team: Woods GM; Muller HK
Year: 1994

Refrigerated centrifuge for immunological and microbiological studies (1992)$18,252

Funding: National Health & Medical Research Council ($18,252)
Scheme: Grant-Equipment
Administered By: University of Tasmania
Research Team: Muller HK; Woods GM; Kirov SM
Year: 1992
Grant Reference: 921213

Langerhans cells and carcinogens (1992 - 1993)$50,000

Funding: Cancer Council of Tasmania ($50,000)
Scheme: Grant
Administered By: University of Tasmania
Research Team: Woods GM
Period: 1992 - 1993

Ultracentrifuge for molecular biological studies (1990)$25,775

Funding: National Health & Medical Research Council ($25,775)
Scheme: Grant-Equipment
Administered By: University of Tasmania
Research Team: West AK; Clark MG; Woods GM
Year: 1990
Grant Reference: 901080

Molecular biological studies of leukaemia (1990 - 1994)$91,844

Funding: David Collins Leukaemia Foundation ($91,844)
Scheme: Grant
Administered By: University of Tasmania
Research Team: Woods GM
Period: 1990 - 1994

Effects of carcinogens on NK cells and other immune defence cells (1990)$4,000

Funding: University of Tasmania ($4,000)
Scheme: Grant-New Staff Research Priming
Administered By: University of Tasmania
Research Team: Woods GM
Year: 1990

Localisation of genes responsible for multiple endocrine neoplasia type-1 (1990)$10,000

Funding: Cancer Council of Tasmania ($10,000)
Scheme: Grant
Administered By: University of Tasmania
Research Team: Wilkinson S; Woods GM
Year: 1990

Research Supervision

Prof Woods is an outstanding supervisor with an endless supply of energy, enthusiasm and patience. His impressive reputation has attracted him numerous honours, masters and PhD candidates. With over 20 PhD candidates successfully supervised to completion, Prof Woods has facilitated many successful careers.

Completed

Degree	Title	Completed
PhD	Manipulation of Devil Facial Tumour Cells to Enhance Immunogenicity Candidate: Chrissie Ee Been Ong	2022
PhD	Immunological Tools and Early Diagnostic Approaches to Monitor the Effects of Devil Facial Tumour Disease on Wild Tasmanian Devils Candidate: Camila Ignacia Espejo Benavides	2021
PhD	Redefining the Role of Tumour Necrosis Factor in Macrophage Differentiation and Effector Function in Bacterial and Tumour Defences Candidate: Xinying Li	2018
PhD	Toll-Like Receptors in the Endangered Tasmanian Devil and Devil Facial Tumour Disease Candidate: Amanda Louise Patchett	2018
PhD	Immune Recognition of Devil Facial Tumour Disease by the Tasmanian Devil Candidate: Ruth Jacqueline Pye	2017
PhD	The Anti-Cancer Activity of the Natural Product, Fucoidan, in Haematological Malignancies Candidate: Farzaneh Atashrazm	2016
PhD	Devil Face Tumour Disease: In vivo studies in mice Candidate: Terry Lee Pinfold	2014
PhD	Manipulating the Immune Response of Tasmanian Devils to Target Devil Facial Tumour Disease Candidate: Gabriella Kathleen Brown	2013
PhD	Insights into the Nature and Immune Escape of a Transmissible Cancer in Tasmanian Devils Candidate: Cesar Dario Tovar Lopez	2012
Unknown	Immune Reconstitution in HIV-I Infection: The Effects of Antiretroviral and Immune Therapy Candidate: Ann Kathleen Sullivan	2011
PhD	Differential Expression of the GM-CSF Gene in the Immune System is Regulated By Epigenetic Factors Candidate: Owen Ralph Sprod	2011
PhD	The Therapeutic Potential of Lentivector-Delivered RNAi Candidate: Nicholas Paul Casey	2010
PhD	Dietary Vitamin D3, the Skin Immune System and Implications for Skin Cancer Candidate: Roslyn Christine Malley	2010
PhD	The Immune Responses of the Tasmanian Devil (Sarchphilus harrissi) and the Devil Facial Tumour Disease Candidate: Alexandre Kreiss	2009
PhD	Neonatal Exposure to Ultraviolet Radiation: Implications for Development and Function of the Skin Immune System Candidate: Heather Margaret McGee	2009
PhD	Proteomic Analysis of Breast Cancer Candidate: Kylie Maree Roberts	2009
PhD	Regulation of Gene Expression by the RUNX1 Transcription Factor Candidate: Phillippa Claire Oakford	2008
PhD	Iron and Pseudomonas aeruginosa Chronic Infection Candidate: Che Yanon O'May	2008
PhD	Clinical Haemopoietic Implications of Fucoidan Treatment Candidate: Mohammad Rassem Irhimeh	2008
Masters	Reducing the Toxicity of Autologous Haemopoetic Stem Cell Transplants Candidate: Nicole Eileen Wright	2006
PhD	Analysis of Antigen Handling by Epidermal Langerhans' Cells during the Early Neonatal Period Candidate: Bernadette Mary Bellette	2005
PhD	Unique Features of the Neonatal Immune System Candidate: Campbell Charles Simpson	2005
PhD	The Role of Ceramide in Growth arrest and terminal differentiation of Human Leukaemia Cells Candidate: Charles Edward Connor	2004
PhD	THE MOLECULAR GENETICS OF FAMILIAL NON-MEDULLARY THYROID CANCER Candidate: James Dowling McKay	2002
PhD	The epidemiology of ulcerative mycosis of the platypus Candidate: Niall John Stewart	2001
PhD	Therapeutic interventions in Alzheimer's disease Candidate: Paul Anthony Adlard	2001
PhD	Re-evaluation of P-glycoprotein in Natural Killer Cells Candidate: Christina Margaret Trambas	2001
PhD	The CNS injury response and its relationship to Alzheimer's Disease Candidate: Carolyn King	2001
PhD	Diseases and immunity in perameles gunnii Candidate: Silvana Santina Bettiol	2000
PhD	The Cellular Mechanism Underlying Neuronal Changes in Alzheimer's Disease Candidate: Tracey Christine Dickson	2000
PhD	Investigation of the effect of chemical carcinogens upon epidermal and dermal cell populations Candidate: Michael John Rist	2000
PhD	Regulation of auto immune diseases Candidate: Yi Peng Chen	1998
Masters	Change in the skin immune system during the development of skin cancer Candidate: Miao Miao Qu	1995
PhD	Title: Expression of Nuclear-Acting Early-Response Genes in the Rat Heart: implications for cardiac hypertrophy Candidate: Ross Duncan Hannan	1994